Here we show that ARTUMES ( ARU) specifically regulates the recognition of interspecific PTs in A. thaliana. ARU, identified in a genome - wide association study ( GWAS ), exclusively influences interspecific — but not intraspecific — gametophyte interactions. ARU encodes the OST3 / 6 subunit of the oligosaccharyltransferase complex conferring protein N - glycosylation.	"ARTUMES	18	25	Gene/Protein"	"ARU	28	31	Gene/Protein"	"ARU	109	112	Gene/Protein"	"ARU	261	264	Gene/Protein"	"OST3	277	281	Gene/Protein"	"oligosaccharyltransferase	301	326	Gene/Protein"	"[{""token"": ""ARTUMES"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 261, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""OST3"", ""start_span"": 277, ""end_span"": 281, ""type"": ""Gene/Protein""}, {""token"": ""oligosaccharyltransferase"", ""start_span"": 301, ""end_span"": 326, ""type"": ""Gene/Protein""}]"
In contrast, aru mutants do not affect gametophytic communication in intraspecific A. thaliana crosses. ARU encodes the OST3 / 6 subunit of the oligosaccharyltransferase complex, which is known to regulate site - and substrate - specific N - glycosylation of proteins in yeast2223 and a similar substrate specificity has been reported for A. thaliana OST3 / 6 ( ref. 24 ).	"aru	13	16	Gene/Protein"	"ARU	104	107	Gene/Protein"	"OST3	120	124	Gene/Protein"	"oligosaccharyltransferase	144	169	Gene/Protein"	"yeast2223	271	280	Organism/Species"	"OST3	351	355	Gene/Protein"	"[{""token"": ""aru"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""OST3"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""oligosaccharyltransferase"", ""start_span"": 144, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""yeast2223"", ""start_span"": 271, ""end_span"": 280, ""type"": ""Organism/Species""}, {""token"": ""OST3"", ""start_span"": 351, ""end_span"": 355, ""type"": ""Gene/Protein""}]"
Mutant aru - 1 plants expressing a functional copy of ARU - GFP in their synergids displayed wild - type - like PT reception in interspecific crosses ( Fig. 5b and Supplementary Fig. 7 ), indicating that ARU expression in synergid cells is sufficient to complement the aru mutant phenotype.	"aru - 1	7	14	Gene/Protein"	"plants	15	21	Organism/Species"	"ARU	54	57	Gene/Protein"	"GFP	60	63	Gene/Protein"	"ARU	204	207	Gene/Protein"	"aru	269	272	Gene/Protein"	"[{""token"": ""aru - 1"", ""start_span"": 7, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 15, ""end_span"": 21, ""type"": ""Organism/Species""}, {""token"": ""ARU"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""aru"", ""start_span"": 269, ""end_span"": 272, ""type"": ""Gene/Protein""}]"
However, it is conceivable that additional regulatory sequences, up - or downstream of the ARU coding sequence that are present in the pARU :: ARU construct but not in pMYB98 :: ARU - GFP or pFER :: ARU - GFP, contributed to the observed phenotypic variability.	"ARU	91	94	Gene/Protein"	"ARU	136	139	Gene/Protein"	"ARU	143	146	Gene/Protein"	"GFP	184	187	Gene/Protein"	"ARU	199	202	Gene/Protein"	"GFP	205	208	Gene/Protein"	"[{""token"": ""ARU"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Gene/Protein""}]"
Moreover, FER ( a receptor - like kinase with an extracellular malectin - binding domain) and LRE ( a glycosylphosphatidylinositol - anchored protein) are likely to be glycosylated131646 and could be substrates of ARU.	"FER	10	13	Gene/Protein"	"receptor - like kinase	18	40	Gene/Protein"	"malectin	63	71	Gene/Protein"	"LRE	94	97	Gene/Protein"	"glycosylphosphatidylinositol - anchored protein	102	149	Gene/Protein"	"ARU	214	217	Gene/Protein"	"[{""token"": ""FER"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""receptor - like kinase"", ""start_span"": 18, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""malectin"", ""start_span"": 63, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""LRE"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""glycosylphosphatidylinositol - anchored protein"", ""start_span"": 102, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Gene/Protein""}]"
We further show that the S100 A8 / 9 complex is a primary regulatory molecule regulating cell survival via CD11b / CD18 and TLR4, and through a signaling mechanism involving MEK - ERK.	"S100 A8	25	32	Gene/Protein"	"CD11b	107	112	Gene/Protein"	"CD18	115	119	Gene/Protein"	"TLR4	124	128	Gene/Protein"	"MEK	174	177	Gene/Protein"	"ERK	180	183	Gene/Protein"	"[{""token"": ""S100 A8"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""CD18"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""MEK"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene/Protein""}]"
However, Vogl et al demonstrated that S100A8 specifically interacts with the TLR4 - MD2 complex [ 29 ], and Newton RA et al suggested that a pertusis toxin - sensitive G - coupled protein receptor could be the S100A9 receptor [ 30 ].	"S100A8	38	44	Gene/Protein"	"TLR4	77	81	Gene/Protein"	"MD2	84	87	Gene/Protein"	"pertusis toxin	141	155	Gene/Protein"	"G - coupled protein receptor	168	196	Gene/Protein"	"S100A9 receptor	210	225	Gene/Protein"	"[{""token"": ""S100A8"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""MD2"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""pertusis toxin"", ""start_span"": 141, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""G - coupled protein receptor"", ""start_span"": 168, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""S100A9 receptor"", ""start_span"": 210, ""end_span"": 225, ""type"": ""Gene/Protein""}]"
Freshly isolated neutrophils express CD11b / CD18 ( isotype control is shown as filled histogram and anti - CD11b / CD18 - PE in dotted line, middle) but not CD36 ( left ).	"CD11b	37	42	Gene/Protein"	"CD18	45	49	Gene/Protein"	"CD11b	108	113	Gene/Protein"	"CD18	116	120	Gene/Protein"	"PE	123	125	Gene/Protein"	"CD36	158	162	Gene/Protein"	"[{""token"": ""CD11b"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""CD18"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""CD18"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 123, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""CD36"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene/Protein""}]"
CD11b inhibition during constitutive spontaneous neutrophil PCD decreased cell survival by 20 %, and in the presence of S100A8 / 9, CD11b inhibition cut the survival effect of S100A8 / 9 by 50 − 75% ( Fig. 5C ), suggesting that S100A8 / 9 may exert its survival effect, at least in part, by either binding or expressing CD11b, a known receptor involved in neutrophil apoptosis.	"CD11b	0	5	Gene/Protein"	"S100A8	120	126	Gene/Protein"	"CD11b	132	137	Gene/Protein"	"S100A8	176	182	Gene/Protein"	"S100A8	228	234	Gene/Protein"	"CD11b	320	325	Gene/Protein"	"[{""token"": ""CD11b"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""S100A8"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""S100A8"", ""start_span"": 176, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""S100A8"", ""start_span"": 228, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 320, ""end_span"": 325, ""type"": ""Gene/Protein""}]"
Extracellular signal - regulated kinase ( ERK ), one of the mitogen - activated protein kinases ( MAPK ), is involved in integrin signaling and Toll - like receptors in general.	"Extracellular signal - regulated kinase	0	39	Gene/Protein"	"ERK	42	45	Gene/Protein"	"mitogen - activated protein kinases	60	95	Gene/Protein"	"MAPK	98	102	Gene/Protein"	"integrin	121	129	Gene/Protein"	"Toll - like receptors	144	165	Gene/Protein"	"[{""token"": ""Extracellular signal - regulated kinase"", ""start_span"": 0, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinases"", ""start_span"": 60, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""integrin"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""Toll - like receptors"", ""start_span"": 144, ""end_span"": 165, ""type"": ""Gene/Protein""}]"
Freshly isolated neutrophils with or without treatment with 2 µg / ml S100A8 / 9 for various times as indicated, and then prepared for intracellular staining with mouse anti - human phospho - p44 / 42 MAPK alexa fluor 488 ( gray) or isotype control ( black ), as described in Materials and methods.	"S100A8	70	76	Gene/Protein"	"mouse	163	168	Organism/Species"	"human	176	181	Organism/Species"	"p44	192	195	Gene/Protein"	"MAPK	201	205	Gene/Protein"	"alexa fluor 488	206	221	Chemical/Drug"	"[{""token"": ""S100A8"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Organism/Species""}, {""token"": ""p44"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""alexa fluor 488"", ""start_span"": 206, ""end_span"": 221, ""type"": ""Chemical/Drug""}]"
The primer sequences were as follows: jmjd2b forward: 5 ′- AAGAAGGGTGGGGTGGCGAA - 3 ′; jmjd2b reverse: 5 ′- CGCCACGTCCTATGGACAATG - 3 ′; Cre forward: 5 ′- AGGTTCGTTCTCTCATGGA - 3 ′; Cre reverse: 5 ′- TCGACCAGTTTAGTTACCC - 3 ′; mTau forward: 5 ′- TATGGCTGACCCTCGCCAGGAGTTT - 3 ′; mTau reverse: 5 ′- GTCCACCCCACTGACCTTTTAAGCC - 3 ′.	"jmjd2b	38	44	Gene/Protein"	"jmjd2b	87	93	Gene/Protein"	"Cre	137	140	Gene/Protein"	"Cre	182	185	Gene/Protein"	"mTau	227	231	Gene/Protein"	"mTau	279	283	Gene/Protein"	"[{""token"": ""jmjd2b"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""jmjd2b"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Cre"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""Cre"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""mTau"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""mTau"", ""start_span"": 279, ""end_span"": 283, ""type"": ""Gene/Protein""}]"
After washing in PBS - T, the membrane was incubated with a horseradish peroxidase - conjugated anti - mouse IgG or anti - rabbit IgG antibody ( 1: 5000, Cell Signaling Technology ).	"horseradish	60	71	Organism/Species"	"peroxidase	72	82	Gene/Protein"	"mouse	103	108	Organism/Species"	"IgG	109	112	Gene/Protein"	"rabbit	123	129	Organism/Species"	"IgG	130	133	Gene/Protein"	"[{""token"": ""horseradish"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""peroxidase"", ""start_span"": 72, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}]"
Unpaired t - tests were applied to compare: expression levels of JMJD2B, JMJD2C, PSD95 ( Supplementary Figure 3 ), Homer2, Rhob and Rhog ( Supplementary Figure 6) in the hippocampus; spine number ( Supplementary Figure 4b ), structure ( Supplementary Figure 4a ), dendrite number and length in the hippocampus and somatosensory cortex.	"JMJD2B	65	71	Gene/Protein"	"JMJD2C	73	79	Gene/Protein"	"PSD95	81	86	Gene/Protein"	"Homer2	115	121	Gene/Protein"	"Rhob	123	127	Gene/Protein"	"Rhog	132	136	Gene/Protein"	"[{""token"": ""JMJD2B"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""JMJD2C"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""PSD95"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""Homer2"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Rhob"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""Rhog"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}]"
To assess the cell types expressing JMJD2B in the hippocampus, we performed immunostaining with DAB as the substrate for horseradish peroxidase using NeuN, GFAP and GAD67 primary antibody followed by in situ hybridization.	"JMJD2B	36	42	Gene/Protein"	"horseradish	121	132	Organism/Species"	"peroxidase	133	143	Gene/Protein"	"NeuN	150	154	Gene/Protein"	"GFAP	156	160	Gene/Protein"	"GAD67	165	170	Gene/Protein"	"[{""token"": ""JMJD2B"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""horseradish"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Organism/Species""}, {""token"": ""peroxidase"", ""start_span"": 133, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""NeuN"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""GFAP"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""GAD67"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}]"
However, the expression level of Jmjd2c, a histone demethylase enzyme closely related to JMJD2B, was not changed in these mice ( Figure 2a right ). In situ hybridization for Jmjd2b confirmed deletion of this gene in these mice ( Figure 2b ).	"Jmjd2c	33	39	Gene/Protein"	"histone demethylase	43	62	Gene/Protein"	"JMJD2B	89	95	Gene/Protein"	"mice	122	126	Organism/Species"	"Jmjd2b	174	180	Gene/Protein"	"mice	222	226	Organism/Species"	"[{""token"": ""Jmjd2c"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""histone demethylase"", ""start_span"": 43, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""JMJD2B"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Organism/Species""}, {""token"": ""Jmjd2b"", ""start_span"": 174, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Organism/Species""}]"
For the remainder of the paper, we refer to mice lacking JMJD2B in neurons as JMJD2B mutant mice and exon 5 - biallelic flanked mice as WT mice.	"mice	44	48	Organism/Species"	"JMJD2B	57	63	Gene/Protein"	"JMJD2B	78	84	Gene/Protein"	"mice	92	96	Organism/Species"	"mice	128	132	Organism/Species"	"mice	139	143	Organism/Species"	"[{""token"": ""mice"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""JMJD2B"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""JMJD2B"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Organism/Species""}]"
As our observations of impaired dendritic spine formation in JMJD2B mutant mice suggested that JMJD2B has an important role in the formation of neural networks in the CNS, we hypothesized that JMJD2B mutant mice might display abnormal behavior reminiscent of neurodevelopmental disorders.	"JMJD2B	61	67	Gene/Protein"	"mice	75	79	Organism/Species"	"JMJD2B	95	101	Gene/Protein"	"JMJD2B	193	199	Gene/Protein"	"mice	207	211	Organism/Species"	"neurodevelopmental disorders	259	287	Disease/Disorder"	"[{""token"": ""JMJD2B"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Organism/Species""}, {""token"": ""JMJD2B"", ""start_span"": 95, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""JMJD2B"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Organism/Species""}, {""token"": ""neurodevelopmental disorders"", ""start_span"": 259, ""end_span"": 287, ""type"": ""Disease/Disorder""}]"
Actin - binding proteins, postsynaptic scaffolding proteins and low - molecular - GTP - binding proteins have been reported to be important factors involved in these processes. 44 Transcriptional silencing of such factors by JMJD2B depletion may alter their expression level, which may in turn underlie the increase in total spine number with a decrease in mature spines that we observed in the hippocampal CA1 region of JMJD2B mutant mice.	"Actin - binding proteins	0	24	Gene/Protein"	"scaffolding proteins	39	59	Gene/Protein"	"GTP - binding proteins	82	104	Gene/Protein"	"JMJD2B	225	231	Gene/Protein"	"JMJD2B	421	427	Gene/Protein"	"mice	435	439	Organism/Species"	"[{""token"": ""Actin - binding proteins"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""scaffolding proteins"", ""start_span"": 39, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""GTP - binding proteins"", ""start_span"": 82, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""JMJD2B"", ""start_span"": 225, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""JMJD2B"", ""start_span"": 421, ""end_span"": 427, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 435, ""end_span"": 439, ""type"": ""Organism/Species""}]"
A differential genome - wide expression study for JMJD2B - deficient ES cells reported that gene expression of several genes involved in synaptic function such as Homer2, Rhob and Rhog was changed. 47, 48, 49 However, the expression level of these genes was not changed in hippocampus of JMJD2B mutant mice in our experimental paradigm ( Supplementary Figure 6 ).	"JMJD2B	50	56	Gene/Protein"	"Homer2	163	169	Gene/Protein"	"Rhob	171	175	Gene/Protein"	"Rhog	180	184	Gene/Protein"	"JMJD2B	288	294	Gene/Protein"	"mice	302	306	Organism/Species"	"[{""token"": ""JMJD2B"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""Homer2"", ""start_span"": 163, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""Rhob"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""Rhog"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""JMJD2B"", ""start_span"": 288, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 302, ""end_span"": 306, ""type"": ""Organism/Species""}]"
Myelin - oligodendrocyte - glycoprotein ( MOG )- induced experimental autoimmune encephalomyelitis ( EAE) in rats reproduces major aspects of the human pathology ( Weissert et al ., 1998b; Storch et al ., 1998; Kornek et al ., 2000; Weissert, 2016 ).	"Myelin - oligodendrocyte - glycoprotein	0	39	Gene/Protein"	"MOG	42	45	Gene/Protein"	"experimental autoimmune encephalomyelitis	57	98	Disease/Disorder"	"EAE	101	104	Disease/Disorder"	"rats	109	113	Organism/Species"	"human	146	151	Organism/Species"	"[{""token"": ""Myelin - oligodendrocyte - glycoprotein"", ""start_span"": 0, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""experimental autoimmune encephalomyelitis"", ""start_span"": 57, ""end_span"": 98, ""type"": ""Disease/Disorder""}, {""token"": ""EAE"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Disease/Disorder""}, {""token"": ""rats"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Organism/Species""}]"
In contrast to merely T - cell - mediated animal models, the pathogenesis of MOG - induced EAE in the rat involves the combined action of T and B cells, antibodies and macrophages, mimicking type II lesions in MS ( Genain et al ., 1995; Mathey et al ., 2004; Lucchinetti et al ., 2000 ).	"animal	42	48	Organism/Species"	"MOG	77	80	Gene/Protein"	"EAE	91	94	Disease/Disorder"	"rat	102	105	Organism/Species"	"antibodies	153	163	Gene/Protein"	"MS	210	212	Disease/Disorder"	"[{""token"": ""animal"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""MOG"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""EAE"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Disease/Disorder""}, {""token"": ""rat"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Organism/Species""}, {""token"": ""antibodies"", ""start_span"": 153, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""MS"", ""start_span"": 210, ""end_span"": 212, ""type"": ""Disease/Disorder""}]"
The induction of active EAE in LEW MHC congenic rat strains and Dark Agouti ( DA) ( RT1av1) rats does not require the application of pertussis toxin like in mice.	"EAE	24	27	Disease/Disorder"	"MHC	35	38	Gene/Protein"	"rat	48	51	Organism/Species"	"rats	92	96	Organism/Species"	"pertussis toxin	133	148	Gene/Protein"	"mice	157	161	Organism/Species"	"[{""token"": ""EAE"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Disease/Disorder""}, {""token"": ""MHC"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""rat"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""pertussis toxin"", ""start_span"": 133, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Organism/Species""}]"
Besides Cxcr4 and Cd38, which were subsequently analyzed in greater detail, many genes with a known function in EAE and MS pathology were found to have an increased expression in MOG 91 - 108 - immunized rats as compared to controls.	"Cxcr4	8	13	Gene/Protein"	"Cd38	18	22	Gene/Protein"	"EAE	112	115	Disease/Disorder"	"MS	120	122	Disease/Disorder"	"MOG	179	182	Gene/Protein"	"rats	204	208	Organism/Species"	"[{""token"": ""Cxcr4"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""Cd38"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""EAE"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Disease/Disorder""}, {""token"": ""MS"", ""start_span"": 120, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""MOG"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Organism/Species""}]"
Owing to their strong expression in MOG 91 - 108 - immunized rats compared to naive, CFA - immunized and MOG 73 - 90 - immunized rats, we chose Cxcr4 and Cd38 for further analysis.	"MOG	36	39	Gene/Protein"	"rats	61	65	Organism/Species"	"MOG	105	108	Gene/Protein"	"rats	129	133	Organism/Species"	"Cxcr4	144	149	Gene/Protein"	"Cd38	154	158	Gene/Protein"	"[{""token"": ""MOG"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""MOG"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Organism/Species""}, {""token"": ""Cxcr4"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""Cd38"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}]"
Next, we assessed the mRNA expression of Cxcr4 ( Fig. 2A) and its ligand Cxcl12 ( Fig. 2B) in spinal cord of either naive DA ( RT1av1) rats or DA ( RT1av1) rats immunized with IFA or CFA alone or MOG 1 - 125 in IFA or MOG 1 - 125 in CFA ( each n = 4 ).	"Cxcr4	41	46	Gene/Protein"	"Cxcl12	73	79	Gene/Protein"	"rats	135	139	Organism/Species"	"rats	156	160	Organism/Species"	"MOG	196	199	Gene/Protein"	"MOG	218	221	Gene/Protein"	"[{""token"": ""Cxcr4"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""Cxcl12"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Organism/Species""}, {""token"": ""MOG"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 218, ""end_span"": 221, ""type"": ""Gene/Protein""}]"
To functionally validate our data and to elucidate the role of CD38 in EAE, we induced disease with the extracellular domain of MOG ( MOG 1 - 125) in Cd38 - knockout ( B6. 129P2 - Cd38tm1Lnd / J) mice and appropriate controls.	"CD38	63	67	Gene/Protein"	"EAE	71	74	Disease/Disorder"	"MOG	128	131	Gene/Protein"	"MOG	134	137	Gene/Protein"	"Cd38	150	154	Gene/Protein"	"mice	196	200	Organism/Species"	"[{""token"": ""CD38"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""EAE"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Disease/Disorder""}, {""token"": ""MOG"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Cd38"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Organism/Species""}]"
Reduced anti - MOG IgG autoantibody responses in B6. 129P2 - Cd38tm1Lnd / J mice ( n = 4) compared to wild - type control mice ( n = 4, ANOVA, P < 0. 05) after immunization with MOG 1 - 125 were seen ( Fig. 4B) on day 12 post - immunization ( p. i .).	"MOG	15	18	Gene/Protein"	"IgG	19	22	Gene/Protein"	"autoantibody	23	35	Gene/Protein"	"mice	76	80	Organism/Species"	"mice	122	126	Organism/Species"	"MOG	178	181	Gene/Protein"	"[{""token"": ""MOG"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""autoantibody"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Organism/Species""}, {""token"": ""MOG"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene/Protein""}]"
FTY720 treatment led to downregulation of S1p1 and Akt2 as well as Cd38, but not of Cxcr4 ( ANOVA for all except Cxcr4, * P < 0. 0001) on day 14 p. i. from cells derived from LNs.	"FTY720	0	6	Chemical/Drug"	"S1p1	42	46	Gene/Protein"	"Akt2	51	55	Gene/Protein"	"Cd38	67	71	Gene/Protein"	"Cxcr4	84	89	Gene/Protein"	"Cxcr4	113	118	Gene/Protein"	"[{""token"": ""FTY720"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical/Drug""}, {""token"": ""S1p1"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""Akt2"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""Cd38"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""Cxcr4"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""Cxcr4"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene/Protein""}]"
Several modulating factors such as phosphatases, regulator of G - protein signaling, adaptor proteins and ubiquitin may affect signaling and / or chemotactic response of CXCR4 to its ligand ( CXCL12 ).	"phosphatases	35	47	Gene/Protein"	"regulator of G - protein signaling	49	83	Gene/Protein"	"adaptor proteins	85	101	Gene/Protein"	"ubiquitin	106	115	Gene/Protein"	"CXCR4	170	175	Gene/Protein"	"CXCL12	192	198	Gene/Protein"	"[{""token"": ""phosphatases"", ""start_span"": 35, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""regulator of G - protein signaling"", ""start_span"": 49, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""adaptor proteins"", ""start_span"": 85, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitin"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""CXCR4"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""CXCL12"", ""start_span"": 192, ""end_span"": 198, ""type"": ""Gene/Protein""}]"
Chemotaxis and integrin - mediated adhesion are the main cellular responses to CXCL12. Cxcl12 - knockout mice display the same phenotype as Cxcr4 - knockout mice ( Nagasawa et al ., 1996 ).	"integrin	15	23	Gene/Protein"	"CXCL12	79	85	Gene/Protein"	"Cxcl12	87	93	Gene/Protein"	"mice	105	109	Organism/Species"	"Cxcr4	140	145	Gene/Protein"	"mice	157	161	Organism/Species"	"[{""token"": ""integrin"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""CXCL12"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Cxcl12"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""Cxcr4"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Organism/Species""}]"
CD38 ligation in B cells leads to tyrosine phosphorylation of several intracellular proteins such as Syk, p85 of phophatidylinositol - 3 kinase and phospholipase C - γ ( Silvennoinen et al ., 1996 ).	"CD38	0	4	Gene/Protein"	"tyrosine	34	42	Chemical/Drug"	"Syk	101	104	Gene/Protein"	"p85	106	109	Gene/Protein"	"phophatidylinositol - 3 kinase	113	143	Gene/Protein"	"phospholipase C - γ	148	167	Gene/Protein"	"[{""token"": ""CD38"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""Syk"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""p85"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""phophatidylinositol - 3 kinase"", ""start_span"": 113, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase C - \u03b3"", ""start_span"": 148, ""end_span"": 167, ""type"": ""Gene/Protein""}]"
We induced EAE in Cd38 - knockout mice ( B6. 129P2 - Cd38tm1Lnd / J) and controls. Cd38 - knockout mice had a reduced disease severity and lower autoantibody and T - cell responses as compared to the controls.	"EAE	11	14	Disease/Disorder"	"Cd38	18	22	Gene/Protein"	"mice	34	38	Organism/Species"	"Cd38	53	57	Gene/Protein"	"mice	99	103	Organism/Species"	"autoantibody	145	157	Gene/Protein"	"[{""token"": ""EAE"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Disease/Disorder""}, {""token"": ""Cd38"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Organism/Species""}, {""token"": ""Cd38"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Organism/Species""}, {""token"": ""autoantibody"", ""start_span"": 145, ""end_span"": 157, ""type"": ""Gene/Protein""}]"
IK2 phosphorylates the translation initiation factor eIF2alpha and down - regulates protein synthesis [ 12 ], [ 13 ]. P. berghei lacking UIS1 / IK2 display a partial loss of infectivity associated with premature transformation of sporozoites in the mosquito salivary glands [ 12 ].	"IK2	0	3	Gene/Protein"	"translation initiation factor	23	52	Gene/Protein"	"eIF2alpha	53	62	Gene/Protein"	"UIS1	137	141	Gene/Protein"	"IK2	144	147	Gene/Protein"	"mosquito	249	257	Organism/Species"	"[{""token"": ""IK2"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""translation initiation factor"", ""start_span"": 23, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""eIF2alpha"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""UIS1"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IK2"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""mosquito"", ""start_span"": 249, ""end_span"": 257, ""type"": ""Organism/Species""}]"
We first assessed the expression of Puf1 and Puf2 during P. berghei development in the insect vector, in comparison to DOZI and UIS1 / IK2, using quantitative RT - PCR ( Figure 1 ).	"Puf1	36	40	Gene/Protein"	"Puf2	45	49	Gene/Protein"	"insect	87	93	Organism/Species"	"DOZI	119	123	Gene/Protein"	"UIS1	128	132	Gene/Protein"	"IK2	135	138	Gene/Protein"	"[{""token"": ""Puf1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Puf2"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""insect"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Organism/Species""}, {""token"": ""DOZI"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""UIS1"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""IK2"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}]"
( A – B) Replacement strategy to generate the puf1 (-) and puf2 (-) parasites. P. berghei PUF1 gene ( A) consists of five exons encoding an 1183 amino - acid protein ( PBANKA_123350 ), whereas PUF2 ( B) consists of four exons encoding a 477 amino - acid protein ( PBANKA_071920 ).	"puf1	46	50	Gene/Protein"	"puf2	59	63	Gene/Protein"	"PUF1	90	94	Gene/Protein"	"amino - acid	145	157	Chemical/Drug"	"PUF2	193	197	Gene/Protein"	"amino - acid	241	253	Chemical/Drug"	"[{""token"": ""puf1"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""puf2"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""PUF1"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""amino - acid"", ""start_span"": 145, ""end_span"": 157, ""type"": ""Chemical/Drug""}, {""token"": ""PUF2"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""amino - acid"", ""start_span"": 241, ""end_span"": 253, ""type"": ""Chemical/Drug""}]"
Whereas early after infection a vast majority ( 81% ± 3 %; n = 122) of intracellular WT sporozoites expressed UIS4, a transmembrane protein that localizes to the membrane of the PV [ 27 ], only half of puf2 (-) parasites were stained with UIS4 antibodies ( 53% ± 9 %; n = 127 ).	"infection	20	29	Disease/Disorder"	"UIS4	110	114	Gene/Protein"	"transmembrane protein	118	139	Gene/Protein"	"puf2	202	206	Gene/Protein"	"UIS4	239	243	Gene/Protein"	"antibodies	244	254	Gene/Protein"	"[{""token"": ""infection"", ""start_span"": 20, ""end_span"": 29, ""type"": ""Disease/Disorder""}, {""token"": ""UIS4"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""transmembrane protein"", ""start_span"": 118, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""puf2"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""UIS4"", ""start_span"": 239, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 244, ""end_span"": 254, ""type"": ""Gene/Protein""}]"
( A) Fluorescence microscopy of WT and puf2 (-) sporozoites isolated from mosquito salivary glands 25 days after infection, and labelled with anti - UIS4 ( red) and anti - CSP ( green) antibodies.	"puf2	39	43	Gene/Protein"	"mosquito	74	82	Organism/Species"	"infection	113	122	Disease/Disorder"	"UIS4	149	153	Gene/Protein"	"CSP	172	175	Gene/Protein"	"antibodies	185	195	Gene/Protein"	"[{""token"": ""puf2"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""mosquito"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""UIS4"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""CSP"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 185, ""end_span"": 195, ""type"": ""Gene/Protein""}]"
Whereas expression of UIS1 / IK2 was not modified in puf1 (-) sporozoites, we observed a ∼ 14 fold reduction of UIS1 / IK2 mRNA in Puf2 - deficient sporozoites as compared to WT ( Figure 7 ).	"UIS1	22	26	Gene/Protein"	"IK2	29	32	Gene/Protein"	"puf1	53	57	Gene/Protein"	"UIS1	112	116	Gene/Protein"	"IK2	119	122	Gene/Protein"	"Puf2	131	135	Gene/Protein"	"[{""token"": ""UIS1"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""IK2"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""puf1"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""UIS1"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IK2"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Puf2"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}]"
Molecular structures of: ( a) Rosiglitzaone with tyrosine moiety ( ssO ), ( b) Rosiglitzaone with tertiary alkylamine moiety ( sssN ), ( c) AD - 7075 and BRL48482 with oxazole moiety ( aaO ), and ( d) Two carboxylic acid agonists with Fmoc - like moiety ( aaaC ). All moiety structures are colored in blue and the atom of the ES symbol is colored in red.	"Rosiglitzaone	30	43	Chemical/Drug"	"tyrosine	49	57	Chemical/Drug"	"Rosiglitzaone	79	92	Chemical/Drug"	"tertiary alkylamine	98	117	Chemical/Drug"	"AD - 7075	140	149	Chemical/Drug"	"BRL48482	154	162	Chemical/Drug"	"[{""token"": ""Rosiglitzaone"", ""start_span"": 30, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""tyrosine"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""Rosiglitzaone"", ""start_span"": 79, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""tertiary alkylamine"", ""start_span"": 98, ""end_span"": 117, ""type"": ""Chemical/Drug""}, {""token"": ""AD - 7075"", ""start_span"": 140, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""BRL48482"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"
A switch of continuation phase tuberculosis ( TB) treatment regimen from Ethambutol ( E) and Isoniazid ( H) combination for 6 months ( 6EH) to Rifampicin ( R) and Isoniazid ( H) combination for 4 months ( 4RH) was recommended.	"tuberculosis	31	43	Disease/Disorder"	"TB	46	48	Disease/Disorder"	"Ethambutol	73	83	Chemical/Drug"	"Isoniazid	93	102	Chemical/Drug"	"Rifampicin	143	153	Chemical/Drug"	"Isoniazid	163	172	Chemical/Drug"	"[{""token"": ""tuberculosis"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Disease/Disorder""}, {""token"": ""TB"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Disease/Disorder""}, {""token"": ""Ethambutol"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""Isoniazid"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""Rifampicin"", ""start_span"": 143, ""end_span"": 153, ""type"": ""Chemical/Drug""}, {""token"": ""Isoniazid"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Chemical/Drug""}]"
These observations, together with a decreased level of MYCN and inhibition of neuroblastoma cell growth in the presence of STAT3 inhibitors, suggest that activation of STAT3 is important for ALK signaling activity in neuroblastoma.	"MYCN	55	59	Gene/Protein"	"neuroblastoma	78	91	Disease/Disorder"	"STAT3	123	128	Gene/Protein"	"STAT3	168	173	Gene/Protein"	"ALK	191	194	Gene/Protein"	"neuroblastoma	217	230	Disease/Disorder"	"[{""token"": ""MYCN"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""neuroblastoma"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Disease/Disorder""}, {""token"": ""STAT3"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""neuroblastoma"", ""start_span"": 217, ""end_span"": 230, ""type"": ""Disease/Disorder""}]"
Recently, tyrosine kinase inhibitors targeting anaplastic lymphoma kinase ( ALK) have been approved for the treatment of ALK - positive non - small - cell - lung - cancer ( NSCLC) 2.	"tyrosine kinase	10	25	Gene/Protein"	"anaplastic lymphoma kinase	47	73	Gene/Protein"	"ALK	76	79	Gene/Protein"	"ALK	121	124	Gene/Protein"	"non - small - cell - lung - cancer	136	170	Disease/Disorder"	"NSCLC	173	178	Disease/Disorder"	"[{""token"": ""tyrosine kinase"", ""start_span"": 10, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""anaplastic lymphoma kinase"", ""start_span"": 47, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""non - small - cell - lung - cancer"", ""start_span"": 136, ""end_span"": 170, ""type"": ""Disease/Disorder""}, {""token"": ""NSCLC"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Disease/Disorder""}]"
One of the proteins that was most significantly tyrosine - phosphorylated in response to ALK activation in our analysis was signal transducer and activator of transcription 3 ( STAT3 ), which has previously been reported to be phosphorylated by both the full - length ALK and ALK fusion proteins 24 – 27.	"tyrosine	48	56	Chemical/Drug"	"ALK	89	92	Gene/Protein"	"signal transducer and activator of transcription 3	124	174	Gene/Protein"	"STAT3	177	182	Gene/Protein"	"ALK	268	271	Gene/Protein"	"ALK	276	279	Gene/Protein"	"[{""token"": ""tyrosine"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Chemical/Drug""}, {""token"": ""ALK"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription 3"", ""start_span"": 124, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 177, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 268, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 276, ""end_span"": 279, ""type"": ""Gene/Protein""}]"
The network model illustrated two of the identified phosphoproteins with increased phosphorylation as potential direct targets of ALK following ALK induction, namely PTPN11 ( SHP - 2) and STAT3.	"phosphoproteins	52	67	Gene/Protein"	"ALK	130	133	Gene/Protein"	"ALK	144	147	Gene/Protein"	"PTPN11	166	172	Gene/Protein"	"SHP - 2	175	182	Gene/Protein"	"STAT3	188	193	Gene/Protein"	"[{""token"": ""phosphoproteins"", ""start_span"": 52, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""PTPN11"", ""start_span"": 166, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""SHP - 2"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 188, ""end_span"": 193, ""type"": ""Gene/Protein""}]"
However, an interaction between STAT3 and ALK was observed on immmunoprecipitation of tagged STAT3, when wild - type ALK was transiently cotransfected with FLAG - tagged STAT3 ( Fig. 2B ).	"STAT3	32	37	Gene/Protein"	"ALK	42	45	Gene/Protein"	"STAT3	93	98	Gene/Protein"	"ALK	117	120	Gene/Protein"	"FLAG	156	160	Gene/Protein"	"STAT3	170	175	Gene/Protein"	"[{""token"": ""STAT3"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""FLAG"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}]"
Given recent observations that ALK regulates MYCN transcription in neuroblastoma cells and collaborates with MYCN in neuroblastoma pathogenesis 34 – 37, we decided to investigate a role for STAT3 in this process.	"ALK	31	34	Gene/Protein"	"MYCN	45	49	Gene/Protein"	"neuroblastoma	67	80	Disease/Disorder"	"MYCN	109	113	Gene/Protein"	"neuroblastoma	117	130	Disease/Disorder"	"STAT3	190	195	Gene/Protein"	"[{""token"": ""ALK"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""MYCN"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""neuroblastoma"", ""start_span"": 67, ""end_span"": 80, ""type"": ""Disease/Disorder""}, {""token"": ""MYCN"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""neuroblastoma"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Disease/Disorder""}, {""token"": ""STAT3"", ""start_span"": 190, ""end_span"": 195, ""type"": ""Gene/Protein""}]"
The ALK inhibitor crizotinib was employed as a control, leading to a reduction in the phosphorylation of STAT3 and ALK, expression of MYCN and phosphorylation of ERK ( Fig. 4A – D, compare lane 2 with lanes 1, 3 and 4 ).	"ALK	4	7	Gene/Protein"	"crizotinib	18	28	Chemical/Drug"	"STAT3	105	110	Gene/Protein"	"ALK	115	118	Gene/Protein"	"MYCN	134	138	Gene/Protein"	"ERK	162	165	Gene/Protein"	"[{""token"": ""ALK"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""crizotinib"", ""start_span"": 18, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""STAT3"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""MYCN"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Gene/Protein""}]"
Of the phosphorylated tyrosines identified outside of the activation loop, Tyr1507 of ALK lies within a consensus Shc - binding site ( NPTpY ), and has been shown to be critical for interaction of full - length ALK with Shc 23.	"phosphorylated	7	21	Chemical/Drug"	"tyrosines	22	31	Chemical/Drug"	"ALK	86	89	Gene/Protein"	"Shc	114	117	Gene/Protein"	"ALK	211	214	Gene/Protein"	"Shc	220	223	Gene/Protein"	"[{""token"": ""phosphorylated"", ""start_span"": 7, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""tyrosines"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""ALK"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""Shc"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""Shc"", ""start_span"": 220, ""end_span"": 223, ""type"": ""Gene/Protein""}]"
One study of NPM – ALK has suggested that oncogenic ALK binds and activates STAT3 directly via the first tyrosine ( Tyr1278) in the Y ′ RAS ′ YY motif of ALK 45.	"NPM	13	16	Gene/Protein"	"ALK	19	22	Gene/Protein"	"ALK	52	55	Gene/Protein"	"STAT3	76	81	Gene/Protein"	"tyrosine	105	113	Chemical/Drug"	"ALK	154	157	Gene/Protein"	"[{""token"": ""NPM"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""ALK"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}]"
Although the precise molecular mechanisms underlying ALK activation of STAT3 are unknown, it is clear from these studies that loss of STAT3 activity, either by RNA interference - mediated knockdown of STAT3 or by addition of STAT3 inhibitors 41, 42, reduces the growth and viability of four neuroblastoma lines.	"ALK	53	56	Gene/Protein"	"STAT3	71	76	Gene/Protein"	"STAT3	134	139	Gene/Protein"	"STAT3	201	206	Gene/Protein"	"STAT3	225	230	Gene/Protein"	"neuroblastoma	291	304	Disease/Disorder"	"[{""token"": ""ALK"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""neuroblastoma"", ""start_span"": 291, ""end_span"": 304, ""type"": ""Disease/Disorder""}]"
Recent work has highlighted the cooperative roles of ALK and MYCN in neuroblastoma, with ALK impacting on both the level of MYCN transcription and the stability of the MYCN protein itself 34 – 37.	"ALK	53	56	Gene/Protein"	"MYCN	61	65	Gene/Protein"	"neuroblastoma	69	82	Disease/Disorder"	"ALK	89	92	Gene/Protein"	"MYCN	124	128	Gene/Protein"	"MYCN	168	172	Gene/Protein"	"[{""token"": ""ALK"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""MYCN"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""neuroblastoma"", ""start_span"": 69, ""end_span"": 82, ""type"": ""Disease/Disorder""}, {""token"": ""ALK"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""MYCN"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""MYCN"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene/Protein""}]"
The following primers were used: human MYCN ( forward, 5 ′- ACCACAAGGCCCTCAGTACC - 3 ′; reverse, 5 ′- TCTCCACAGTGACCACGTCGATTT - 3 ′); human RPL19 ( forward, 5 ′- AACACATCCACAAGCTGAAGGCAG - 3 ′; reverse, 5 ′- TCTTCACGGCGCTTGCGT - 3 ′); and human RPL29 ( forward, 5 ′- ATGGCCAAGTCCAAGAACCACA - 3 ′; reverse, 5 ′- TTGGCATTGTTGGCCTGCAT - 3 ′).	"human	33	38	Organism/Species"	"MYCN	39	43	Gene/Protein"	"human	135	140	Organism/Species"	"RPL19	141	146	Gene/Protein"	"human	240	245	Organism/Species"	"RPL29	246	251	Gene/Protein"	"[{""token"": ""human"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Organism/Species""}, {""token"": ""MYCN"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""RPL19"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 240, ""end_span"": 245, ""type"": ""Organism/Species""}, {""token"": ""RPL29"", ""start_span"": 246, ""end_span"": 251, ""type"": ""Gene/Protein""}]"
Second, western blot analysis demonstrated that hBD3 dose - dependently suppressed the protein levels of intracellular adhesion molecule - 1 ( ICAM - 1) and vascular cell adhesion molecule - 1 ( VCAM - 1) in TNF - α - induced HUVECs.	"hBD3	48	52	Gene/Protein"	"intracellular adhesion molecule - 1	105	140	Gene/Protein"	"ICAM - 1	143	151	Gene/Protein"	"vascular cell adhesion molecule - 1	157	192	Gene/Protein"	"VCAM - 1	195	203	Gene/Protein"	"TNF - α	208	215	Gene/Protein"	"[{""token"": ""hBD3"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""intracellular adhesion molecule - 1"", ""start_span"": 105, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 143, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 157, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 208, ""end_span"": 215, ""type"": ""Gene/Protein""}]"
Moreover, the phosphorylation of p38 and c - Jun N - terminal protein kinase ( JNK) in the mitogen - activated protein kinase ( MAPK) pathway were also inhibited by hBD3 in HUVECs.	"p38	33	36	Gene/Protein"	"c - Jun N - terminal protein kinase	41	76	Gene/Protein"	"JNK	79	82	Gene/Protein"	"mitogen - activated protein kinase	91	125	Gene/Protein"	"MAPK	128	132	Gene/Protein"	"hBD3	165	169	Gene/Protein"	"[{""token"": ""p38"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun N - terminal protein kinase"", ""start_span"": 41, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 91, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""hBD3"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}]"
Antiphosphorylated and total IκBα, p65, p38, ERK, and JNK antibodies were purchased from Cell Signaling Technology ( Beverly, MA ).	"IκBα	29	33	Gene/Protein"	"p65	35	38	Gene/Protein"	"p38	40	43	Gene/Protein"	"ERK	45	48	Gene/Protein"	"JNK	54	57	Gene/Protein"	"antibodies	58	68	Gene/Protein"	"[{""token"": ""I\u03baB\u03b1"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""p38"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Gene/Protein""}]"
To evaluate whether 2ccPA has potential beneficial effects on the pathology of multiple sclerosis, we investigated the effects of 2ccPA on oligodendrocyte cell death in vitro and administrated 2ccPA to mouse models of experimental autoimmune encephalomyelitis ( EAE) and cuprizone - induced demyelination.	"multiple sclerosis	79	97	Disease/Disorder"	"mouse	202	207	Organism/Species"	"experimental autoimmune encephalomyelitis	218	259	Disease/Disorder"	"EAE	262	265	Disease/Disorder"	"cuprizone	271	280	Chemical/Drug"	"demyelination	291	304	Disease/Disorder"	"[{""token"": ""multiple sclerosis"", ""start_span"": 79, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""mouse"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Organism/Species""}, {""token"": ""experimental autoimmune encephalomyelitis"", ""start_span"": 218, ""end_span"": 259, ""type"": ""Disease/Disorder""}, {""token"": ""EAE"", ""start_span"": 262, ""end_span"": 265, ""type"": ""Disease/Disorder""}, {""token"": ""cuprizone"", ""start_span"": 271, ""end_span"": 280, ""type"": ""Chemical/Drug""}, {""token"": ""demyelination"", ""start_span"": 291, ""end_span"": 304, ""type"": ""Disease/Disorder""}]"
The most commonly studied animal models of multiple sclerosis are the autoimmune experimental autoimmune encephalomyelitis ( EAE) model [ 4, 5] and the cuprizone ( bis - cyclohexanone - oxalyldihydrazone, CPZ )- induced demyelination model [ 6, 7 ].	"animal	26	32	Organism/Species"	"multiple sclerosis	43	61	Disease/Disorder"	"experimental autoimmune encephalomyelitis	81	122	Disease/Disorder"	"EAE	125	128	Disease/Disorder"	"cuprizone	152	161	Chemical/Drug"	"demyelination	220	233	Disease/Disorder"	"[{""token"": ""animal"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""multiple sclerosis"", ""start_span"": 43, ""end_span"": 61, ""type"": ""Disease/Disorder""}, {""token"": ""experimental autoimmune encephalomyelitis"", ""start_span"": 81, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""EAE"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Disease/Disorder""}, {""token"": ""cuprizone"", ""start_span"": 152, ""end_span"": 161, ""type"": ""Chemical/Drug""}, {""token"": ""demyelination"", ""start_span"": 220, ""end_span"": 233, ""type"": ""Disease/Disorder""}]"
The mRNA levels of Iba1 ( a ), GFAP ( b ), NLRP3 ( c ), P2X7R ( d ), and IL - 1β ( e) relative to PGK1, as determined by qPCR in the corpus callosum after 5 weeks of CPZ exposure.	"Iba1	19	23	Gene/Protein"	"GFAP	31	35	Gene/Protein"	"NLRP3	43	48	Gene/Protein"	"P2X7R	56	61	Gene/Protein"	"IL - 1β	73	80	Gene/Protein"	"PGK1	98	102	Gene/Protein"	"[{""token"": ""Iba1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""GFAP"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""NLRP3"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""P2X7R"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""PGK1"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}]"
Neuroinflammation ( e. g ., lymphocyte / macrophage infiltration, microglial activation, enhanced cytokine / chemokine production, demyelination, and axonal damage [ 35 – 37 ]) is a key component of the pathological progression of all subtypes of multiple sclerosis and in both the EAE and cuprizone models.	"cytokine	98	106	Gene/Protein"	"chemokine	109	118	Gene/Protein"	"demyelination	131	144	Disease/Disorder"	"multiple sclerosis	247	265	Disease/Disorder"	"EAE	282	285	Disease/Disorder"	"cuprizone	290	299	Chemical/Drug"	"[{""token"": ""cytokine"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""chemokine"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""demyelination"", ""start_span"": 131, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""multiple sclerosis"", ""start_span"": 247, ""end_span"": 265, ""type"": ""Disease/Disorder""}, {""token"": ""EAE"", ""start_span"": 282, ""end_span"": 285, ""type"": ""Disease/Disorder""}, {""token"": ""cuprizone"", ""start_span"": 290, ""end_span"": 299, ""type"": ""Chemical/Drug""}]"
Visualizing reagents used were ninhydrin reagent ( 0. 2 g ninhydrin in 100 mL ethanol) to detect peptides, anthrone reagent ( 1 g anthrone in 5 mL sulfuric acid mixed with 95 mL ethanol) to examine sugars and lipid portion was evidenced using rhodamine B reagent ( 0. 25 g in 100 mL ethanol ).	"ninhydrin	31	40	Chemical/Drug"	"ninhydrin	58	67	Chemical/Drug"	"anthrone	107	115	Chemical/Drug"	"anthrone	130	138	Chemical/Drug"	"sugars	198	204	Chemical/Drug"	"rhodamine B	243	254	Chemical/Drug"	"[{""token"": ""ninhydrin"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""ninhydrin"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""anthrone"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""anthrone"", ""start_span"": 130, ""end_span"": 138, ""type"": ""Chemical/Drug""}, {""token"": ""sugars"", ""start_span"": 198, ""end_span"": 204, ""type"": ""Chemical/Drug""}, {""token"": ""rhodamine B"", ""start_span"": 243, ""end_span"": 254, ""type"": ""Chemical/Drug""}]"
During primary chondrogenesis, which is activated by transforming growth factor beta ( TGF - β ), Sox9 binds to essential sequences in the Col2A1 gene enhancers and initiates its expression [ 19 ]. The functional modulation of Sox9 is a critical step for the initiation of chondrogenesis and is mainly regulated by histone acetylation [ 20 ].	"transforming growth factor beta	53	84	Gene/Protein"	"TGF - β	87	94	Gene/Protein"	"Sox9	98	102	Gene/Protein"	"Col2A1	139	145	Gene/Protein"	"Sox9	227	231	Gene/Protein"	"histone	315	322	Gene/Protein"	"[{""token"": ""transforming growth factor beta"", ""start_span"": 53, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""TGF - \u03b2"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""Col2A1"", ""start_span"": 139, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""histone"", ""start_span"": 315, ""end_span"": 322, ""type"": ""Gene/Protein""}]"
Data represent mean ± SEM ( n = 3 ). * p < 0. 05, ** p < 0. 01. BMSCs bone marrow mesenchymal stem cells, Col2A1 α1 chain of type II collagen, MLA methyllycaconitine, NFATc2 nuclear factor of activated T cell 2, Sox9 SRY - type high - mobility group box 9	"Col2A1	106	112	Gene/Protein"	"α1 chain of type II collagen	113	141	Gene/Protein"	"NFATc2	167	173	Gene/Protein"	"nuclear factor of activated T cell 2	174	210	Gene/Protein"	"Sox9	212	216	Gene/Protein"	"SRY - type high - mobility group box 9	217	255	Gene/Protein"	"[{""token"": ""Col2A1"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""\u03b11 chain of type II collagen"", ""start_span"": 113, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cell 2"", ""start_span"": 174, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""SRY - type high - mobility group box 9"", ""start_span"": 217, ""end_span"": 255, ""type"": ""Gene/Protein""}]"
The result of ChIP analysis indicated that the binding of NFATc2 and HDAC1 on the Sox9 promoter was increased ( Fig. 5c and d) and that H3K9ac and H3K14ac levels on the Sox9 promoter were reduced ( Fig. 5a and b) while a decreased binding of Sox9 on Col2A1 was also observed ( Fig. 5e ).	"NFATc2	58	64	Gene/Protein"	"HDAC1	69	74	Gene/Protein"	"Sox9	82	86	Gene/Protein"	"Sox9	169	173	Gene/Protein"	"Sox9	242	246	Gene/Protein"	"Col2A1	250	256	Gene/Protein"	"[{""token"": ""NFATc2"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""HDAC1"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 242, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""Col2A1"", ""start_span"": 250, ""end_span"": 256, ""type"": ""Gene/Protein""}]"
Reduced binding of Sox9 with Col2A1 further decreased Col2A1 expression. Fig. 5Effects of nicotine on histone acetylation on the promoter of Sox9 in BMSCs.	"Sox9	19	23	Gene/Protein"	"Col2A1	29	35	Gene/Protein"	"Col2A1	54	60	Gene/Protein"	"nicotine	90	98	Chemical/Drug"	"histone	102	109	Gene/Protein"	"Sox9	141	145	Gene/Protein"	"[{""token"": ""Sox9"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""Col2A1"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Col2A1"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""histone"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene/Protein""}]"
HDAC1 is the protein of interest. BMSCs bone marrow mesenchymal stem cells, HDAC1 histone deacetylase1, MLA methyllycaconitine, NFATc2 nuclear factor of activated T cell 2	"HDAC1	0	5	Gene/Protein"	"HDAC1	76	81	Gene/Protein"	"histone deacetylase1	82	102	Gene/Protein"	"methyllycaconitine	108	126	Chemical/Drug"	"NFATc2	128	134	Gene/Protein"	"nuclear factor of activated T cell 2	135	171	Gene/Protein"	"[{""token"": ""HDAC1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""HDAC1"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""histone deacetylase1"", ""start_span"": 82, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""methyllycaconitine"", ""start_span"": 108, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""NFATc2"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cell 2"", ""start_span"": 135, ""end_span"": 171, ""type"": ""Gene/Protein""}]"
Based on our previous study, we further confirmed nicotine ’ s suppression of Col2A1 expression and chondrogenic differentiation of BMSCs, the mechanism of which may involve decreasing the histone acetylation of the Sox9 promoter region through activation of Ca2 +/ CaN / NFAT signaling.	"nicotine	50	58	Chemical/Drug"	"Col2A1	78	84	Gene/Protein"	"histone	189	196	Gene/Protein"	"Sox9	216	220	Gene/Protein"	"CaN	266	269	Gene/Protein"	"NFAT	272	276	Gene/Protein"	"[{""token"": ""nicotine"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""Col2A1"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""histone"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""CaN"", ""start_span"": 266, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Gene/Protein""}]"
Based on the dose – conversion correlation between humans and rats ( human: rats = 1: 6. 17) [ 52 ], the dose of nicotine exposure in the present study is equivalent to the nicotine exposure in an adult weighing approximately 70 kg smoking 2. 3 cigarettes per day ( calculated as follows: 2 mg / kg / d ÷ 6. 17 × 70 kg ÷ 10 mg / cigarette = 2. 3 cigarettes / d ).	"humans	51	57	Organism/Species"	"rats	62	66	Organism/Species"	"human	69	74	Organism/Species"	"rats	76	80	Organism/Species"	"nicotine	113	121	Chemical/Drug"	"nicotine	173	181	Chemical/Drug"	"[{""token"": ""humans"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Organism/Species""}, {""token"": ""nicotine"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 173, ""end_span"": 181, ""type"": ""Chemical/Drug""}]"
When in stress state, the hypothalamus releases CRH and AVP in response to a stressor, which in turn activate the secretion of ACTH from the pituitary, which finally stimulates the secretion of cortisol ( in humans) or CORT ( in rodents) from the adrenal cortex [ 21 ].	"CRH	48	51	Gene/Protein"	"AVP	56	59	Gene/Protein"	"ACTH	127	131	Gene/Protein"	"cortisol	194	202	Chemical/Drug"	"humans	208	214	Organism/Species"	"rodents	229	236	Organism/Species"	"[{""token"": ""CRH"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""AVP"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""ACTH"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""cortisol"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Chemical/Drug""}, {""token"": ""humans"", ""start_span"": 208, ""end_span"": 214, ""type"": ""Organism/Species""}, {""token"": ""rodents"", ""start_span"": 229, ""end_span"": 236, ""type"": ""Organism/Species""}]"
Some previous studies have shown that there are significant increases of AVP neurons expression and AVP level in the paraventricular nucleus, AVP reactivity in the pituitary, and AVP mRNA expression in the supraoptic nucleus in depressed patients [ 27, 28 ], which also suggests that AVP changes in the paraventricular nucleus and supraoptic nucleus may be the basis for the onset of depression.	"AVP	73	76	Gene/Protein"	"AVP	100	103	Gene/Protein"	"AVP	142	145	Gene/Protein"	"AVP	179	182	Gene/Protein"	"AVP	284	287	Gene/Protein"	"depression	384	394	Disease/Disorder"	"[{""token"": ""AVP"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""AVP"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""AVP"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""AVP"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""AVP"", ""start_span"": 284, ""end_span"": 287, ""type"": ""Gene/Protein""}, {""token"": ""depression"", ""start_span"": 384, ""end_span"": 394, ""type"": ""Disease/Disorder""}]"
More recently, it was shown that the transcription factor Klf15 is encoded by a clock - controlled gene, and that Klf15 maintains nitrogen balance via regulation of the second urea cycle gene Otc [ 19 ].	"transcription factor	37	57	Gene/Protein"	"Klf15	58	63	Gene/Protein"	"clock	80	85	Gene/Protein"	"Klf15	114	119	Gene/Protein"	"urea	176	180	Chemical/Drug"	"Otc	192	195	Gene/Protein"	"[{""token"": ""transcription factor"", ""start_span"": 37, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Klf15"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""clock"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Klf15"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""urea"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""Otc"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}]"
These results suggested that the proximal C / EBP consensus site plays a major role in mediating the NOB induction of Cps1. Fig. 4C / EBP binding site mutations in proximal and distal Cps1 enhancer regions impaired NOB - mediated reporter activation. a Diagram of distal and proximal C / EBP sites on the Cps1 promoter region. b and c Hepa1 - 6 cells were transfected with reporter constructs containing wild - type ( WT; white bars) and C / EBP binding site mutated ( black bars) enhancer regions, and treated with NOB at the indicated doses.	"C / EBP	42	49	Gene/Protein"	"Cps1	118	122	Gene/Protein"	"Cps1	184	188	Gene/Protein"	"C / EBP	284	291	Gene/Protein"	"Cps1	305	309	Gene/Protein"	"C / EBP	438	445	Gene/Protein"	"[{""token"": ""C / EBP"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Cps1"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Cps1"", ""start_span"": 184, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP"", ""start_span"": 284, ""end_span"": 291, ""type"": ""Gene/Protein""}, {""token"": ""Cps1"", ""start_span"": 305, ""end_span"": 309, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP"", ""start_span"": 438, ""end_span"": 445, ""type"": ""Gene/Protein""}]"
Total RNAs were purified for real - time RT - PCR analysis using primers for the four urea cycle genes, including Otc ( b ), Ass1c, Asl d and Arg1 e. RC regular chow, HFD high - fat diet, Veh vehicle, NOB Nobiletin.	"urea	86	90	Chemical/Drug"	"Otc	114	117	Gene/Protein"	"Ass1c	125	130	Gene/Protein"	"Asl	132	135	Gene/Protein"	"Arg1	142	146	Gene/Protein"	"Nobiletin	205	214	Chemical/Drug"	"[{""token"": ""urea"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""Otc"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Ass1c"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Asl"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""Arg1"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Nobiletin"", ""start_span"": 205, ""end_span"": 214, ""type"": ""Chemical/Drug""}]"
Student ’ s t - test, WT vs. Clk, Cps1: CT4, * p < 0. 05; Cebpa: CT8, * p < 0. 05; Cebpb: CT8, ** p < 0. 01. c Western blot analysis of CPS1 protein levels in liver samples collected at ZT8 and ZT20 from WT and Clk mice subjected to the indicated diet and treatment. RC regular chow, HFD high - fat diet, Veh vehicle, NOB Nobiletin.	"Cps1	34	38	Gene/Protein"	"Cebpa	58	63	Gene/Protein"	"Cebpb	83	88	Gene/Protein"	"CPS1	136	140	Gene/Protein"	"mice	215	219	Organism/Species"	"Nobiletin	322	331	Chemical/Drug"	"[{""token"": ""Cps1"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Cebpa"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Cebpb"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""CPS1"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Organism/Species""}, {""token"": ""Nobiletin"", ""start_span"": 322, ""end_span"": 331, ""type"": ""Chemical/Drug""}]"
The predominant 164KD band was validated by mass spectrometry as CPS1 ( Table S3 ). ( C) Control microscopy images for Fig. 2b using rabbit IgG. Figure S2. NOB rescued C / EBP protein circadian expression in the liver from HFD fed mice. ( A) Quantification of C / EBPα p42 protein levels from three independent experiments including the blot shown in Fig. 3b.	"CPS1	65	69	Gene/Protein"	"rabbit	133	139	Organism/Species"	"C / EBP	168	175	Gene/Protein"	"mice	231	235	Organism/Species"	"C / EBPα	260	268	Gene/Protein"	"p42	269	272	Gene/Protein"	"[{""token"": ""CPS1"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""C / EBP"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 231, ""end_span"": 235, ""type"": ""Organism/Species""}, {""token"": ""C / EBP\u03b1"", ""start_span"": 260, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""p42"", ""start_span"": 269, ""end_span"": 272, ""type"": ""Gene/Protein""}]"
Instead, articles focused on the EU were prioritized as part of the article selection process. Table 1Search terms Databases searched Disease search terms Economic, humanistic and societal burden search terms • Medline “ Herpes Zoster ” OR “ Shingles ” OR “ Post - herpetic Neuralgia ” OR “ Post herpetic Neuralgia ” OR “ Postherpetic Neuralgia ” OR “ PHN ”“ Burden ” OR “ Humanistic ” OR “ quality of life ” OR “ QOL ” OR “ HRQOL ” OR “ cost ” OR “ economic ” OR “ resource ” OR “ society ” OR “ societal ” OR “ family ” OR “ relatives ” OR “ Caregiver ” OR “ care $” OR “ activities of daily living ” OR “ ADLS ” OR “ daily activities ” OR “ cost of illness ” OR “ autonomy ” OR “ hospitalisation ” OR “ hospitalization ” • Embase • PscyINFO • EconLit. • Health Economic Evaluations Database ( HEED) • Centre for Reviews and Dissemination databases: - Database of Abstracts of Reviews of Effects ( DARE ), - Health Technology Assessment ( HTA) - NHS Economic Evaluation Database ( NHS EED)	"Herpes Zoster	221	234	Disease/Disorder"	"Shingles	242	250	Disease/Disorder"	"Post - herpetic Neuralgia	258	283	Disease/Disorder"	"Post herpetic Neuralgia	291	314	Disease/Disorder"	"Postherpetic Neuralgia	322	344	Disease/Disorder"	"PHN	352	355	Disease/Disorder"	"[{""token"": ""Herpes Zoster"", ""start_span"": 221, ""end_span"": 234, ""type"": ""Disease/Disorder""}, {""token"": ""Shingles"", ""start_span"": 242, ""end_span"": 250, ""type"": ""Disease/Disorder""}, {""token"": ""Post - herpetic Neuralgia"", ""start_span"": 258, ""end_span"": 283, ""type"": ""Disease/Disorder""}, {""token"": ""Post herpetic Neuralgia"", ""start_span"": 291, ""end_span"": 314, ""type"": ""Disease/Disorder""}, {""token"": ""Postherpetic Neuralgia"", ""start_span"": 322, ""end_span"": 344, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 352, ""end_span"": 355, ""type"": ""Disease/Disorder""}]"
In Switzerland, reported costs of sick leave per case for patients with varying levels of pain were as follows: mild pain ( HZ € 335; PHN 381 ), moderate pain ( HZ € 421; PHN € 1, 018 ), severe pain ( HZ € 1, 837; PHN € 2, 443) b [ 72 ].	"HZ	124	126	Disease/Disorder"	"PHN	134	137	Disease/Disorder"	"HZ	161	163	Disease/Disorder"	"PHN	171	174	Disease/Disorder"	"HZ	201	203	Disease/Disorder"	"PHN	214	217	Disease/Disorder"	"[{""token"": ""HZ"", ""start_span"": 124, ""end_span"": 126, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 161, ""end_span"": 163, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 201, ""end_span"": 203, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Disease/Disorder""}]"
Rice black - streaked dwarf virus ( RBSDV ), a member of the genus Fijivirus in the family Reoviridae, is propagatively transmitted by the small brown planthopper ( Laodelphax striatellus Fallén ).	"Rice black - streaked dwarf virus	0	33	Organism/Species"	"RBSDV	36	41	Organism/Species"	"Fijivirus	67	76	Organism/Species"	"Reoviridae	91	101	Organism/Species"	"small brown planthopper	139	162	Organism/Species"	"Laodelphax striatellus	165	187	Organism/Species"	"[{""token"": ""Rice black - streaked dwarf virus"", ""start_span"": 0, ""end_span"": 33, ""type"": ""Organism/Species""}, {""token"": ""RBSDV"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""Fijivirus"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Organism/Species""}, {""token"": ""Reoviridae"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Organism/Species""}, {""token"": ""small brown planthopper"", ""start_span"": 139, ""end_span"": 162, ""type"": ""Organism/Species""}, {""token"": ""Laodelphax striatellus"", ""start_span"": 165, ""end_span"": 187, ""type"": ""Organism/Species""}]"
Rice black - streaked dwarf virus ( RBSDV ), a member of the genus Fijivirus in the family Reoviridae, causes rice black - streaked dwarf and maize rough dwarf diseases, which lead to severe yield losses in crops in China, Japan, Korea, and other Asian countries [ 1 ], [ 2 ], [ 3 ].	"Rice black - streaked dwarf virus	0	33	Organism/Species"	"RBSDV	36	41	Organism/Species"	"Fijivirus	67	76	Organism/Species"	"Reoviridae	91	101	Organism/Species"	"rice black - streaked dwarf	110	137	Disease/Disorder"	"maize rough dwarf diseases	142	168	Disease/Disorder"	"[{""token"": ""Rice black - streaked dwarf virus"", ""start_span"": 0, ""end_span"": 33, ""type"": ""Organism/Species""}, {""token"": ""RBSDV"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""Fijivirus"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Organism/Species""}, {""token"": ""Reoviridae"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Organism/Species""}, {""token"": ""rice black - streaked dwarf"", ""start_span"": 110, ""end_span"": 137, ""type"": ""Disease/Disorder""}, {""token"": ""maize rough dwarf diseases"", ""start_span"": 142, ""end_span"": 168, ""type"": ""Disease/Disorder""}]"
To generate the RBSDV P7 - 1 overexpression plasmid, the coding region of the RBSDV P7 - 1 gene ( from + 1 to + 1, 089 bp) was amplified with primers containing the SacI and BamHI sites ( Table S1 ).	"RBSDV	16	21	Organism/Species"	"P7 - 1	22	28	Gene/Protein"	"RBSDV	78	83	Organism/Species"	"P7 - 1	84	90	Gene/Protein"	"SacI	165	169	Gene/Protein"	"BamHI	174	179	Gene/Protein"	"[{""token"": ""RBSDV"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""RBSDV"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""SacI"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""BamHI"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Gene/Protein""}]"
To determine whether proteins encoded by RBSDV contributed to the variation in anther dehiscence and spikelet fertility of virus - infected rice plants, we investigated the effects of P7 - 1 on Arabidopsis plants.	"RBSDV	41	46	Organism/Species"	"virus	123	128	Organism/Species"	"rice plants	140	151	Organism/Species"	"P7 - 1	184	190	Gene/Protein"	"Arabidopsis	194	205	Organism/Species"	"plants	206	212	Organism/Species"	"[{""token"": ""RBSDV"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""rice plants"", ""start_span"": 140, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""Arabidopsis"", ""start_span"": 194, ""end_span"": 205, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Organism/Species""}]"
Moreover, the expression levels of the lignin biosynthesis genes 4CL ( 4 - coumarate: CoAligase ), CCoAOMT ( caffeoyl CoA O - methyltransferase ), and C3H ( cinnamic acid 3 - hydroxylase) were low in P7 - 1 - OE flowers, especially at stage 13 or later, compared with wild - type flowers ( Figure 5C ).	"4CL	65	68	Gene/Protein"	"CCoAOMT	99	106	Gene/Protein"	"caffeoyl CoA O - methyltransferase	109	143	Gene/Protein"	"C3H	151	154	Gene/Protein"	"cinnamic acid 3 - hydroxylase	157	186	Gene/Protein"	"P7 - 1	200	206	Gene/Protein"	"[{""token"": ""4CL"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""CCoAOMT"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""caffeoyl CoA O - methyltransferase"", ""start_span"": 109, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""C3H"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""cinnamic acid 3 - hydroxylase"", ""start_span"": 157, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""P7 - 1"", ""start_span"": 200, ""end_span"": 206, ""type"": ""Gene/Protein""}]"
Previous studies using immunoelectron analysis have revealed that RBSDV P7 - 1 accumulates in tubular structures in virus - infected maize plants and in insects [ 8 ].	"RBSDV	66	71	Organism/Species"	"P7 - 1	72	78	Gene/Protein"	"virus	116	121	Organism/Species"	"maize	133	138	Organism/Species"	"plants	139	145	Organism/Species"	"insects	153	160	Organism/Species"	"[{""token"": ""RBSDV"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""maize"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 139, ""end_span"": 145, ""type"": ""Organism/Species""}, {""token"": ""insects"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Organism/Species""}]"
Furthermore, P7 - 1 of SRBSDV ( southern rice black - streaked dwarf virus ), which is most closely related to RBSDV, has the intrinsic ability to form tubules growing from the non - host insect cell surface in the absence of other virus proteins [ 24 ].	"P7 - 1	13	19	Gene/Protein"	"SRBSDV	23	29	Organism/Species"	"southern rice black - streaked dwarf virus	32	74	Organism/Species"	"RBSDV	111	116	Organism/Species"	"insect	188	194	Organism/Species"	"virus	232	237	Organism/Species"	"[{""token"": ""P7 - 1"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""SRBSDV"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Organism/Species""}, {""token"": ""southern rice black - streaked dwarf virus"", ""start_span"": 32, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""RBSDV"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""insect"", ""start_span"": 188, ""end_span"": 194, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Organism/Species""}]"
Furthermore, the triple ccc mutant, which carries mutations in monolignol biosynthesis genes, including CCR1 ( cinnamoyl CoA reductase1 ), CAD c ( cinnamyl alcohol dehydrogenase c ), and CAD d, displays severe male sterility due to the lack of lignification in the anther endothecium [ 19 ].	"monolignol	63	73	Chemical/Drug"	"CCR1	104	108	Gene/Protein"	"cinnamoyl CoA reductase1	111	135	Gene/Protein"	"CAD c	139	144	Gene/Protein"	"cinnamyl alcohol dehydrogenase c	147	179	Gene/Protein"	"CAD d	187	192	Gene/Protein"	"[{""token"": ""monolignol"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""CCR1"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""cinnamoyl CoA reductase1"", ""start_span"": 111, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""CAD c"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""cinnamyl alcohol dehydrogenase c"", ""start_span"": 147, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""CAD d"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Gene/Protein""}]"
Alexander staining of pollen of P7 - 1 transgenic and wild - type Arabidopsis plants. ( A) Cytological comparisons of P7 - 1 transgenic lines ( P7 - 1 - OE) and wild type ( WT) Arabidopsis anthers during development.	"P7 - 1	32	38	Gene/Protein"	"Arabidopsis	66	77	Organism/Species"	"plants	78	84	Organism/Species"	"P7 - 1	118	124	Gene/Protein"	"P7 - 1	144	150	Gene/Protein"	"Arabidopsis	177	188	Organism/Species"	"[{""token"": ""P7 - 1"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Arabidopsis"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""P7 - 1"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""Arabidopsis"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Organism/Species""}]"
Under basal conditions, most kynurenine is metabolized by astrocytes to KA, an N - methyl - D - aspartate ( NMDA) and α7 - nicotinic acetylcholine receptor antagonist. 23, 24 However, inflammation and subsequent microglial activation is reported to shift kynurenine metabolism toward KMO - dependent production of QA. 20, 25 QA, an NMDAR agonist, can be particularly disruptive to the neuronal environment at higher concentrations, not only by elevating the potential for glutamate excitotoxicty but also by precipitating oxidative damage26 and potentiating pro - inflammation.	"kynurenine	29	39	Chemical/Drug"	"α7 - nicotinic acetylcholine receptor	118	155	Gene/Protein"	"kynurenine	255	265	Chemical/Drug"	"KMO	284	287	Gene/Protein"	"NMDAR	332	337	Gene/Protein"	"glutamate	472	481	Chemical/Drug"	"[{""token"": ""kynurenine"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""\u03b17 - nicotinic acetylcholine receptor"", ""start_span"": 118, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""kynurenine"", ""start_span"": 255, ""end_span"": 265, ""type"": ""Chemical/Drug""}, {""token"": ""KMO"", ""start_span"": 284, ""end_span"": 287, ""type"": ""Gene/Protein""}, {""token"": ""NMDAR"", ""start_span"": 332, ""end_span"": 337, ""type"": ""Gene/Protein""}, {""token"": ""glutamate"", ""start_span"": 472, ""end_span"": 481, ""type"": ""Chemical/Drug""}]"
Importantly, LPS - challenged mice also exhibit depressive - and anxiety - like behaviors concomitant with the elevations in neurotoxic metabolites. 20 Whereas evidence implicates KMO - dependent kynurenine metabolism as a likely pathogenic mechanism underlying inflammation - induced depression, 28 until recently, no preclinical genetic models were available to directly test this hypothesis and brain - penetrant KMO inhibitors are not commercially available.	"mice	30	34	Organism/Species"	"anxiety	65	72	Disease/Disorder"	"KMO	180	183	Gene/Protein"	"kynurenine	196	206	Chemical/Drug"	"depression	285	295	Disease/Disorder"	"KMO	416	419	Gene/Protein"	"[{""token"": ""mice"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""anxiety"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Disease/Disorder""}, {""token"": ""KMO"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""kynurenine"", ""start_span"": 196, ""end_span"": 206, ""type"": ""Chemical/Drug""}, {""token"": ""depression"", ""start_span"": 285, ""end_span"": 295, ""type"": ""Disease/Disorder""}, {""token"": ""KMO"", ""start_span"": 416, ""end_span"": 419, ""type"": ""Gene/Protein""}]"
In order to determine whether KMO - dependent neurotoxic kynurenine metabolism mediates the depressive - like behavioral changes following peripheral immune challenge, two novel transgenic mouse strains were generated with targeted deletion of either the KMO or 3 - hydroxyanthranilic acid dioxygenase ( HAAO) gene.	"KMO	30	33	Gene/Protein"	"kynurenine	57	67	Chemical/Drug"	"mouse	189	194	Organism/Species"	"KMO	255	258	Gene/Protein"	"3 - hydroxyanthranilic acid dioxygenase	262	301	Gene/Protein"	"HAAO	304	308	Gene/Protein"	"[{""token"": ""KMO"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""kynurenine"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""mouse"", ""start_span"": 189, ""end_span"": 194, ""type"": ""Organism/Species""}, {""token"": ""KMO"", ""start_span"": 255, ""end_span"": 258, ""type"": ""Gene/Protein""}, {""token"": ""3 - hydroxyanthranilic acid dioxygenase"", ""start_span"": 262, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""HAAO"", ""start_span"": 304, ""end_span"": 308, ""type"": ""Gene/Protein""}]"
We and others have demonstrated that IDO, the rate - limiting step of kynurenine metabolism ( Figure 1 ), directly mediates the induction of depressive - like behaviors in response to peripheral immune challenge in preclinical models. 14, 16, 33 However, the generation of neuroactive kynurenine metabolites occurs downstream of IDO. 20 Whereas emergent clinical and preclinical data suggest that shifting the balance of downstream kynurenine metabolism to favor production of neurotoxic kynurenines drives depressive symptoms, 19, 20 no mechanistic studies have been performed to directly test this hypothesis.	"IDO	37	40	Gene/Protein"	"kynurenine	70	80	Chemical/Drug"	"kynurenine	285	295	Chemical/Drug"	"IDO	329	332	Gene/Protein"	"kynurenine	432	442	Chemical/Drug"	"kynurenines	488	499	Chemical/Drug"	"[{""token"": ""IDO"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""kynurenine"", ""start_span"": 70, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 285, ""end_span"": 295, ""type"": ""Chemical/Drug""}, {""token"": ""IDO"", ""start_span"": 329, ""end_span"": 332, ""type"": ""Gene/Protein""}, {""token"": ""kynurenine"", ""start_span"": 432, ""end_span"": 442, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenines"", ""start_span"": 488, ""end_span"": 499, ""type"": ""Chemical/Drug""}]"
KMO −/− mice have disrupted central and peripheral kynurenine metabolism ( Table 1) in a similar pattern to this previous study. 39 Interestingly, baseline kynurenine levels are significantly elevated in KMO −/− mice without any apparent changes to baseline depressive - like phenotype.	"KMO	0	3	Gene/Protein"	"mice	8	12	Organism/Species"	"kynurenine	51	61	Chemical/Drug"	"kynurenine	156	166	Chemical/Drug"	"KMO	204	207	Gene/Protein"	"mice	212	216	Organism/Species"	"[{""token"": ""KMO"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Organism/Species""}, {""token"": ""kynurenine"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 156, ""end_span"": 166, ""type"": ""Chemical/Drug""}, {""token"": ""KMO"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Organism/Species""}]"
To determine whether increased neurotoxic kynurenine metabolism generates the metabolic substrates to cause the distinct depressive - like behaviors observed in Figures 3 and 5, kynurenine metabolites were measured in the dorsal hippocampus, ventral hippocampus, central amygdala and nucleus accumbens of C57BL6 / J mice ( Table 2 ), the same background strain of the KMO −/− and HAAO −/− mice, at 24 h post treatment.	"kynurenine	42	52	Chemical/Drug"	"kynurenine	178	188	Chemical/Drug"	"mice	316	320	Organism/Species"	"KMO	368	371	Gene/Protein"	"HAAO	380	384	Gene/Protein"	"mice	389	393	Organism/Species"	"[{""token"": ""kynurenine"", ""start_span"": 42, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Chemical/Drug""}, {""token"": ""mice"", ""start_span"": 316, ""end_span"": 320, ""type"": ""Organism/Species""}, {""token"": ""KMO"", ""start_span"": 368, ""end_span"": 371, ""type"": ""Gene/Protein""}, {""token"": ""HAAO"", ""start_span"": 380, ""end_span"": 384, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 389, ""end_span"": 393, ""type"": ""Organism/Species""}]"
It is also possible that the chronic alterations in kynurenine metabolites that exist in the conventional KMO and HAAO null mice results in a compensatory recalibration of the reward system, as the effects of acute and subchronic elevations in KA on the dopaminergic system are well established. 58, 59 Although no baseline differences in SP were observed, it is of interest to note that the LPS - stimulated increase in nucleus accumbens KA could locally decrease extracellular dopamine, similar to a previously demonstrated effect of exogenous KA application to the striatum. 60 This local reduction in extracellular DA could contribute to the development of anhedonia behavior following LPS treatment.	"kynurenine	52	62	Chemical/Drug"	"KMO	106	109	Gene/Protein"	"HAAO	114	118	Gene/Protein"	"mice	124	128	Organism/Species"	"dopamine	254	262	Chemical/Drug"	"anhedonia	661	670	Disease/Disorder"	"[{""token"": ""kynurenine"", ""start_span"": 52, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""KMO"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""HAAO"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""dopamine"", ""start_span"": 254, ""end_span"": 262, ""type"": ""Chemical/Drug""}, {""token"": ""anhedonia"", ""start_span"": 661, ""end_span"": 670, ""type"": ""Disease/Disorder""}]"
Kynurenine is then either metabolized to kynurenic acid ( KA) by kynurenine aminotransferases ( KATs ), or to 3 - hydroxykynurenine ( 3 - HK, red) by kynurenine - 3 - monooxygenase ( KMO, purple ).	"Kynurenine	0	10	Chemical/Drug"	"kynurenic acid	41	55	Chemical/Drug"	"kynurenine aminotransferases	65	93	Gene/Protein"	"KATs	96	100	Gene/Protein"	"kynurenine - 3 - monooxygenase	150	180	Gene/Protein"	"KMO	183	186	Gene/Protein"	"[{""token"": ""Kynurenine"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenic acid"", ""start_span"": 41, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine aminotransferases"", ""start_span"": 65, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""KATs"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""kynurenine - 3 - monooxygenase"", ""start_span"": 150, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""KMO"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene/Protein""}]"
Elevated ccfDNA concentration levels were observed in patients with HL ( n = 18, median 681. 0 ng / ml, mean 988. 8 ng / ml, P = 0. 001 ), DLBCL ( n = 98, median 845. 0 ng / ml, mean 1722. 2 ng / ml, P < 0. 0001 ), other types of B - NHL ( n = 28, median 332. 0 ng / ml, mean 1096. 3 ng / ml, P < 0. 0001 ), T - NHL ( n = 9, median 942. 0 ng / ml, mean 1247. 0 ng / ml, P < 0. 0001 ), and NK / TCL ( n = 21, median 662. 0 ng / ml, mean 782. 7 ng / ml, P < 0. 0001) ( Fig. 1a ). Fig. 1Circulating cell - free DNA levels in the plasma of lymphoma patients.	"HL	68	70	Disease/Disorder"	"DLBCL	139	144	Disease/Disorder"	"B - NHL	230	237	Disease/Disorder"	"T - NHL	308	315	Disease/Disorder"	"NK / TCL	389	397	Disease/Disorder"	"lymphoma	536	544	Disease/Disorder"	"[{""token"": ""HL"", ""start_span"": 68, ""end_span"": 70, ""type"": ""Disease/Disorder""}, {""token"": ""DLBCL"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""B - NHL"", ""start_span"": 230, ""end_span"": 237, ""type"": ""Disease/Disorder""}, {""token"": ""T - NHL"", ""start_span"": 308, ""end_span"": 315, ""type"": ""Disease/Disorder""}, {""token"": ""NK / TCL"", ""start_span"": 389, ""end_span"": 397, ""type"": ""Disease/Disorder""}, {""token"": ""lymphoma"", ""start_span"": 536, ""end_span"": 544, ""type"": ""Disease/Disorder""}]"
Data from our ROC analysis showed that the AUC of the concentration to distinguish HL, DLBCL, and NK / TCL patients from normal controls was 0. 75, 0. 86, and 0. 79, respectively; furthermore, the AUC of the DII was higher than that of the concentration ( 0. 83, 0. 90, and 0. 81 for HL, DLBCL, and NK / TCL, respectively ), indicating that the ccfDNA concentration alone appeared to be insufficient for a high - quality diagnostic performance.	"HL	83	85	Disease/Disorder"	"DLBCL	87	92	Disease/Disorder"	"NK / TCL	98	106	Disease/Disorder"	"HL	284	286	Disease/Disorder"	"DLBCL	288	293	Disease/Disorder"	"NK / TCL	299	307	Disease/Disorder"	"[{""token"": ""HL"", ""start_span"": 83, ""end_span"": 85, ""type"": ""Disease/Disorder""}, {""token"": ""DLBCL"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Disease/Disorder""}, {""token"": ""NK / TCL"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Disease/Disorder""}, {""token"": ""HL"", ""start_span"": 284, ""end_span"": 286, ""type"": ""Disease/Disorder""}, {""token"": ""DLBCL"", ""start_span"": 288, ""end_span"": 293, ""type"": ""Disease/Disorder""}, {""token"": ""NK / TCL"", ""start_span"": 299, ""end_span"": 307, ""type"": ""Disease/Disorder""}]"
The bison lineage ( including wisent, American bison and the extinct steppe bison) is thought to have diverged from the Bos cattle lineage around 0. 85 – 1. 7 YBP, and likely included an extended period of geneflow ( Gautier et al.	"bison	4	9	Organism/Species"	"wisent	30	36	Organism/Species"	"American bison	38	52	Organism/Species"	"steppe bison	69	81	Organism/Species"	"Bos	120	123	Organism/Species"	"cattle	124	130	Organism/Species"	"[{""token"": ""bison"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Organism/Species""}, {""token"": ""wisent"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Organism/Species""}, {""token"": ""American bison"", ""start_span"": 38, ""end_span"": 52, ""type"": ""Organism/Species""}, {""token"": ""steppe bison"", ""start_span"": 69, ""end_span"": 81, ""type"": ""Organism/Species""}, {""token"": ""Bos"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Organism/Species""}, {""token"": ""cattle"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Organism/Species""}]"
Analysis of aligned 1 Mb genomic blocks involved the modern LC line wisent ( MdLC ), the founding wisent ( PLATEN) that was found to be least admixed with Caucasian wisent, Caucasian wisent ( Cc1) and domestic cattle, with water buffalo as outgroup.	"wisent	68	74	Organism/Species"	"wisent	98	104	Organism/Species"	"Caucasian wisent	155	171	Organism/Species"	"Caucasian wisent	173	189	Organism/Species"	"domestic cattle	201	216	Organism/Species"	"water buffalo	223	236	Organism/Species"	"[{""token"": ""wisent"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""wisent"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Organism/Species""}, {""token"": ""Caucasian wisent"", ""start_span"": 155, ""end_span"": 171, ""type"": ""Organism/Species""}, {""token"": ""Caucasian wisent"", ""start_span"": 173, ""end_span"": 189, ""type"": ""Organism/Species""}, {""token"": ""domestic cattle"", ""start_span"": 201, ""end_span"": 216, ""type"": ""Organism/Species""}, {""token"": ""water buffalo"", ""start_span"": 223, ""end_span"": 236, ""type"": ""Organism/Species""}]"
We investigated potential admixture between wisent and the Bos cattle lineage using pseudo - haploid sequences generated from short read data of two domestic Holstein cows and an ancient aurochs ( Bos primigenius; Park et al.	"wisent	44	50	Organism/Species"	"Bos	59	62	Organism/Species"	"cattle	63	69	Organism/Species"	"cows	167	171	Organism/Species"	"aurochs	187	194	Organism/Species"	"Bos primigenius	197	212	Organism/Species"	"[{""token"": ""wisent"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""Bos"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Organism/Species""}, {""token"": ""cattle"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Organism/Species""}, {""token"": ""cows"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Organism/Species""}, {""token"": ""aurochs"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Organism/Species""}, {""token"": ""Bos primigenius"", ""start_span"": 197, ""end_span"": 212, ""type"": ""Organism/Species""}]"
This suggests either admixture between wisent and domestic cattle, or alternatively, admixture with aurochs, if aurochs populations were highly structured and the admixing individuals were from a population more closely related to domestic cattle than the British aurochs used in this analysis.	"wisent	39	45	Organism/Species"	"domestic cattle	50	65	Organism/Species"	"aurochs	100	107	Organism/Species"	"aurochs	112	119	Organism/Species"	"domestic cattle	231	246	Organism/Species"	"aurochs	264	271	Organism/Species"	"[{""token"": ""wisent"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Organism/Species""}, {""token"": ""domestic cattle"", ""start_span"": 50, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""aurochs"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""aurochs"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""domestic cattle"", ""start_span"": 231, ""end_span"": 246, ""type"": ""Organism/Species""}, {""token"": ""aurochs"", ""start_span"": 264, ""end_span"": 271, ""type"": ""Organism/Species""}]"
This complex history involved not only admixture resulting directly from the captive breeding program, but also older processes occurring prior to their extinction in the wild, which included admixture with the Bos cattle lineage ( fig. 8 ). Fig. 8Schematic diagram showing inferred admixture among wisent, and among wisent and the cattle / aurochs lineage.	"Bos	211	214	Organism/Species"	"cattle	215	221	Organism/Species"	"wisent	299	305	Organism/Species"	"wisent	317	323	Organism/Species"	"cattle	332	338	Organism/Species"	"aurochs	341	348	Organism/Species"	"[{""token"": ""Bos"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Organism/Species""}, {""token"": ""cattle"", ""start_span"": 215, ""end_span"": 221, ""type"": ""Organism/Species""}, {""token"": ""wisent"", ""start_span"": 299, ""end_span"": 305, ""type"": ""Organism/Species""}, {""token"": ""wisent"", ""start_span"": 317, ""end_span"": 323, ""type"": ""Organism/Species""}, {""token"": ""cattle"", ""start_span"": 332, ""end_span"": 338, ""type"": ""Organism/Species""}, {""token"": ""aurochs"", ""start_span"": 341, ""end_span"": 348, ""type"": ""Organism/Species""}]"
Thus, based on the current evidence, cattle introgression appears of low concern for wisent conservation for the following reasons: ( 1) admixture does not appear to have occurred since the establishment of the captive breeding program, although screening of additional individuals may be desirable to further support this generalization; ( 2) the number of intervening generations separating living wisent from the F1 hybrids is likely sufficient that all living wisent are admixed to some extent ( Chang 1999 ); and ( 3) our results may in fact reflect admixture with aurochs, rather than domestic cattle, although this hypothesis requires further investigation.	"cattle	37	43	Organism/Species"	"wisent	85	91	Organism/Species"	"wisent	400	406	Organism/Species"	"wisent	464	470	Organism/Species"	"aurochs	570	577	Organism/Species"	"domestic cattle	591	606	Organism/Species"	"[{""token"": ""cattle"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Organism/Species""}, {""token"": ""wisent"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Organism/Species""}, {""token"": ""wisent"", ""start_span"": 400, ""end_span"": 406, ""type"": ""Organism/Species""}, {""token"": ""wisent"", ""start_span"": 464, ""end_span"": 470, ""type"": ""Organism/Species""}, {""token"": ""aurochs"", ""start_span"": 570, ""end_span"": 577, ""type"": ""Organism/Species""}, {""token"": ""domestic cattle"", ""start_span"": 591, ""end_span"": 606, ""type"": ""Organism/Species""}]"
There is emerging evidence that mood disorders [ 16 ], anxiety disorders [ 17 ], trauma - related disorders [ 18 – 20 ], sexual disorders [ 21, 22] and schizophrenia [ 23] are also associated with negative or disturbed body image.	"mood disorders	32	46	Disease/Disorder"	"anxiety disorders	55	72	Disease/Disorder"	"trauma - related disorders	81	107	Disease/Disorder"	"sexual disorders	121	137	Disease/Disorder"	"schizophrenia	152	165	Disease/Disorder"	"disturbed body image	209	229	Disease/Disorder"	"[{""token"": ""mood disorders"", ""start_span"": 32, ""end_span"": 46, ""type"": ""Disease/Disorder""}, {""token"": ""anxiety disorders"", ""start_span"": 55, ""end_span"": 72, ""type"": ""Disease/Disorder""}, {""token"": ""trauma - related disorders"", ""start_span"": 81, ""end_span"": 107, ""type"": ""Disease/Disorder""}, {""token"": ""sexual disorders"", ""start_span"": 121, ""end_span"": 137, ""type"": ""Disease/Disorder""}, {""token"": ""schizophrenia"", ""start_span"": 152, ""end_span"": 165, ""type"": ""Disease/Disorder""}, {""token"": ""disturbed body image"", ""start_span"": 209, ""end_span"": 229, ""type"": ""Disease/Disorder""}]"
A recent study using the DBIQ - NL in a broad clinical sample including mood disorders, anxiety disorders, adjustment disorder, post - traumatic stress disorder, eating disorders, schizophrenia and other psychotic disorders [ 83] gave a first indication of the clinical usefulness of the scale.	"mood disorders	72	86	Disease/Disorder"	"anxiety disorders	88	105	Disease/Disorder"	"adjustment disorder	107	126	Disease/Disorder"	"post - traumatic stress disorder	128	160	Disease/Disorder"	"eating disorders	162	178	Disease/Disorder"	"schizophrenia and other psychotic disorders	180	223	Disease/Disorder"	"[{""token"": ""mood disorders"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Disease/Disorder""}, {""token"": ""anxiety disorders"", ""start_span"": 88, ""end_span"": 105, ""type"": ""Disease/Disorder""}, {""token"": ""adjustment disorder"", ""start_span"": 107, ""end_span"": 126, ""type"": ""Disease/Disorder""}, {""token"": ""post - traumatic stress disorder"", ""start_span"": 128, ""end_span"": 160, ""type"": ""Disease/Disorder""}, {""token"": ""eating disorders"", ""start_span"": 162, ""end_span"": 178, ""type"": ""Disease/Disorder""}, {""token"": ""schizophrenia and other psychotic disorders"", ""start_span"": 180, ""end_span"": 223, ""type"": ""Disease/Disorder""}]"
Using negative binomial regression models, we identified PD - 1, TIGIT and LAG - 3 as immune checkpoint molecules positively associated with the frequency of CD4 + T cells harboring integrated HIV DNA.	"PD - 1	57	63	Gene/Protein"	"TIGIT	65	70	Gene/Protein"	"LAG - 3	75	82	Gene/Protein"	"immune checkpoint molecules	86	113	Gene/Protein"	"CD4	158	161	Gene/Protein"	"HIV	193	196	Organism/Species"	"[{""token"": ""PD - 1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""immune checkpoint molecules"", ""start_span"": 86, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Organism/Species""}]"
Quantification of HIV genomes in highly purified cell subsets from blood further revealed that expressions of PD - 1, TIGIT and LAG - 3 were associated with HIV - infected cells in distinct memory CD4 + T cell subsets.	"HIV	18	21	Organism/Species"	"PD - 1	110	116	Gene/Protein"	"TIGIT	118	123	Gene/Protein"	"LAG - 3	128	135	Gene/Protein"	"HIV	157	160	Organism/Species"	"CD4	197	200	Gene/Protein"	"[{""token"": ""HIV"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Organism/Species""}, {""token"": ""PD - 1"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene/Protein""}]"
( C ), ( D ), ( E) Associations between the frequency of CD4 + T cells harboring integrated HIV DNA and the frequency of CD4 + T cells expressing PD - 1, TIGIT and LAG - 3, respectively.	"CD4	57	60	Gene/Protein"	"HIV	92	95	Organism/Species"	"CD4	121	124	Gene/Protein"	"PD - 1	146	152	Gene/Protein"	"TIGIT	154	159	Gene/Protein"	"LAG - 3	164	171	Gene/Protein"	"[{""token"": ""CD4"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}]"
Using the negative binomial regression model, we found that the frequency of CD4 + T cells not expressing PD - 1, TIGIT and LAG - 3 was strongly and negatively correlated to the frequency of CD4 + T cells harboring integrated HIV DNA ( p = 0. 002, Table 3 and Fig 2C ).	"CD4	77	80	Gene/Protein"	"PD - 1	106	112	Gene/Protein"	"TIGIT	114	119	Gene/Protein"	"LAG - 3	124	131	Gene/Protein"	"CD4	191	194	Gene/Protein"	"HIV	226	229	Organism/Species"	"[{""token"": ""CD4"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 226, ""end_span"": 229, ""type"": ""Organism/Species""}]"
Conversely, the frequency of CD4 + T cell co - expressing PD - 1, TIGIT and LAG - 3 was strongly and positively associated with the frequency of CD4 + T cells harboring integrated HIV DNA ( p = 0. 001, Table 3 and Fig 2F ).	"CD4	29	32	Gene/Protein"	"PD - 1	58	64	Gene/Protein"	"TIGIT	66	71	Gene/Protein"	"LAG - 3	76	83	Gene/Protein"	"CD4	145	148	Gene/Protein"	"HIV	180	183	Organism/Species"	"[{""token"": ""CD4"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Organism/Species""}]"
Interestingly, the frequencies of CD4 + T cells co - expressing TIGIT with either PD - 1 or LAG - 3 were also positively associated with the frequency of CD4 + T cells harboring integrated HIV DNA ( p = 0. 002 and p = 0. 029 respectively, Table 3 and Fig 2D and 2E ).	"CD4	34	37	Gene/Protein"	"TIGIT	64	69	Gene/Protein"	"PD - 1	82	88	Gene/Protein"	"LAG - 3	92	99	Gene/Protein"	"CD4	154	157	Gene/Protein"	"HIV	189	192	Organism/Species"	"[{""token"": ""CD4"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Organism/Species""}]"
Memory CD4 + T cells expressing simultaneously PD - 1, TIGIT and LAG - 3 were enriched for HIV - infected cells up to 10 times more when compared to total CD4 + T cells, with a median fold increase ( IQR) of 8. 15 ( 4. 92 – 9. 59 ).	"CD4	7	10	Gene/Protein"	"PD - 1	47	53	Gene/Protein"	"TIGIT	55	60	Gene/Protein"	"LAG - 3	65	72	Gene/Protein"	"HIV	91	94	Organism/Species"	"CD4	155	158	Gene/Protein"	"[{""token"": ""CD4"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}]"
The frequencies of CD4 + T cells expressing PD - 1, CTLA - 4, LAG - 3 and TIM - 3 were similar to those reported by other groups [ 41 – 44 ], indicating that the cohort of participants used for this study is likely to be representative of the HIV population receiving suppressive ART.	"CD4	19	22	Gene/Protein"	"PD - 1	44	50	Gene/Protein"	"CTLA - 4	52	60	Gene/Protein"	"LAG - 3	62	69	Gene/Protein"	"TIM - 3	74	81	Gene/Protein"	"HIV	243	246	Organism/Species"	"[{""token"": ""CD4"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CTLA - 4"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""TIM - 3"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 243, ""end_span"": 246, ""type"": ""Organism/Species""}]"
In addition, the association between PD - 1 and TIGIT expression on CD4 + T cells and the frequency of CD4 + T cells carrying HIV proviruses was in agreement with previously reported findings [ 6, 24, 41 ].	"PD - 1	37	43	Gene/Protein"	"TIGIT	48	53	Gene/Protein"	"CD4	68	71	Gene/Protein"	"CD4	103	106	Gene/Protein"	"HIV	126	129	Organism/Species"	"proviruses	130	140	Organism/Species"	"[{""token"": ""PD - 1"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Organism/Species""}, {""token"": ""proviruses"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Organism/Species""}]"
Our results suggest that the administration of antibodies with effector functions targeting PD - 1, LAG - 3 and TIGIT may significantly reduce the size of the latent HIV reservoir during ART by targeting cells in which HIV persists.	"antibodies	47	57	Gene/Protein"	"PD - 1	92	98	Gene/Protein"	"LAG - 3	100	107	Gene/Protein"	"TIGIT	112	117	Gene/Protein"	"HIV	166	169	Organism/Species"	"HIV	219	222	Organism/Species"	"[{""token"": ""antibodies"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 219, ""end_span"": 222, ""type"": ""Organism/Species""}]"
The contribution of cells expressing PD - 1 ( A ), TIGIT ( B) or LAG - 3 ( C) to the total HIV reservoir by taking into account the frequency of these subsets within the CD4 compartment and their relative infection frequencies ( n = 12, n = 9 and n = 7, respectively ).	"PD - 1	37	43	Gene/Protein"	"TIGIT	51	56	Gene/Protein"	"LAG - 3	65	72	Gene/Protein"	"HIV	91	94	Organism/Species"	"CD4	170	173	Gene/Protein"	"infection	205	214	Disease/Disorder"	"[{""token"": ""PD - 1"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""infection"", ""start_span"": 205, ""end_span"": 214, ""type"": ""Disease/Disorder""}]"
Real - time analysis for quantification of different bacterial genera in Healthy vs E. histolytica positive ( Eh + ve) samples. ( A) Bacteroides ( B) Clostridium coccoides subgroup ( C) Clostridium leptum subgroup ( D) Lactobacillus ( E) Campylobacter ( F) Eubacterium. P value =. 05 or below was considered significant.	"Bacteroides	133	144	Organism/Species"	"Clostridium coccoides	150	171	Organism/Species"	"Clostridium leptum	186	204	Organism/Species"	"Lactobacillus	219	232	Organism/Species"	"Campylobacter	238	251	Organism/Species"	"Eubacterium	257	268	Organism/Species"	"[{""token"": ""Bacteroides"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Organism/Species""}, {""token"": ""Clostridium coccoides"", ""start_span"": 150, ""end_span"": 171, ""type"": ""Organism/Species""}, {""token"": ""Clostridium leptum"", ""start_span"": 186, ""end_span"": 204, ""type"": ""Organism/Species""}, {""token"": ""Lactobacillus"", ""start_span"": 219, ""end_span"": 232, ""type"": ""Organism/Species""}, {""token"": ""Campylobacter"", ""start_span"": 238, ""end_span"": 251, ""type"": ""Organism/Species""}, {""token"": ""Eubacterium"", ""start_span"": 257, ""end_span"": 268, ""type"": ""Organism/Species""}]"
The genus Lactobacillus comprises a large heterogenous group of low G + C gram positive, non sporulating, anaerobic bacteria belonging to phylum Firmicutes. Lactobacilli are known to fortify epithelial barrier by various mechanism such as induction of mucin secretion, enhancement of tight - junction functioning, upregulation of cytoprotective heat shock proteins and prevention of apoptosis of epithelial cells [ 38 ].	"Lactobacillus	10	23	Organism/Species"	"bacteria	116	124	Organism/Species"	"Firmicutes	145	155	Organism/Species"	"Lactobacilli	157	169	Organism/Species"	"mucin	252	257	Gene/Protein"	"heat shock proteins	345	364	Gene/Protein"	"[{""token"": ""Lactobacillus"", ""start_span"": 10, ""end_span"": 23, ""type"": ""Organism/Species""}, {""token"": ""bacteria"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""Firmicutes"", ""start_span"": 145, ""end_span"": 155, ""type"": ""Organism/Species""}, {""token"": ""Lactobacilli"", ""start_span"": 157, ""end_span"": 169, ""type"": ""Organism/Species""}, {""token"": ""mucin"", ""start_span"": 252, ""end_span"": 257, ""type"": ""Gene/Protein""}, {""token"": ""heat shock proteins"", ""start_span"": 345, ""end_span"": 364, ""type"": ""Gene/Protein""}]"
The reduction of effector memory T cells lacking the expression of CD27 and CD28 and expressing CD57 and KLRG1, observed in CMV - infected offspring could explain their high proliferative response against CMV.	"CD27	67	71	Gene/Protein"	"CD28	76	80	Gene/Protein"	"CD57	96	100	Gene/Protein"	"KLRG1	105	110	Gene/Protein"	"CMV	124	127	Organism/Species"	"CMV	205	208	Organism/Species"	"[{""token"": ""CD27"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""CD57"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""KLRG1"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""CMV"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""CMV"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Organism/Species""}]"
Naïve T cells ( CD3 + CD8 + CD45RA + CCR7 + CD27 + CD28 +)	"CD3	16	19	Gene/Protein"	"CD8	22	25	Gene/Protein"	"CD45RA	28	34	Gene/Protein"	"CCR7	37	41	Gene/Protein"	"CD27	44	48	Gene/Protein"	"CD28	51	55	Gene/Protein"	"[{""token"": ""CD3"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""CD8"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""CD45RA"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""CCR7"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""CD27"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}]"
Late differentiated effector memory T cells ( CD3 + CD8 + CD45RA - CCR7 - CD27 - CD28 -)	"CD3	46	49	Gene/Protein"	"CD8	52	55	Gene/Protein"	"CD45RA	58	64	Gene/Protein"	"CCR7	67	71	Gene/Protein"	"CD27	74	78	Gene/Protein"	"CD28	81	85	Gene/Protein"	"[{""token"": ""CD3"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""CD8"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CD45RA"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""CCR7"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD27"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene/Protein""}]"
TEMRA ( CD3 + CD8 + CD45RA + CCR7 - CD27 - CD28 -)	"CD3	8	11	Gene/Protein"	"CD8	14	17	Gene/Protein"	"CD45RA	20	26	Gene/Protein"	"CCR7	29	33	Gene/Protein"	"CD27	36	40	Gene/Protein"	"CD28	43	47	Gene/Protein"	"[{""token"": ""CD3"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""CD8"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""CD45RA"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""CCR7"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""CD27"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}]"
Two other mutations, H63D ( a histidine to aspartate at amino acid 63) and S65C ( a serine to cysteine at amino acid 65 ), are associated with milder forms of this disease [ 34, 35 ].	"histidine	30	39	Chemical/Drug"	"aspartate	43	52	Chemical/Drug"	"amino acid	56	66	Chemical/Drug"	"serine	84	90	Chemical/Drug"	"cysteine	94	102	Chemical/Drug"	"amino acid	106	116	Chemical/Drug"	"[{""token"": ""histidine"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 43, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""amino acid"", ""start_span"": 56, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""serine"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""cysteine"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""amino acid"", ""start_span"": 106, ""end_span"": 116, ""type"": ""Chemical/Drug""}]"
In order to confirm our suggestions on the biological effects of + 896A / G TLR4 SNP and its role in the pathophysiology of age - related diseases studied ( i. e. MI and PC) and longevity, we recently assessed the levels of IL - 6, TNF - α, IL - 10 and eicosanoids in LPS - stimulated whole blood samples from 50 young healthy Sicilians, screened for the presence of this SNP.	"TLR4	76	80	Gene/Protein"	"PC	170	172	Disease/Disorder"	"IL - 6	224	230	Gene/Protein"	"TNF - α	232	239	Gene/Protein"	"IL - 10	241	248	Gene/Protein"	"eicosanoids	253	264	Chemical/Drug"	"[{""token"": ""TLR4"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""PC"", ""start_span"": 170, ""end_span"": 172, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 6"", ""start_span"": 224, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 232, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 241, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""eicosanoids"", ""start_span"": 253, ""end_span"": 264, ""type"": ""Chemical/Drug""}]"
Curcumin, resveratrol, polyphenols and flavonoids, phytoestrogen, and lycopene are also considered key nutritional factors both for regulation of enzyme involved in acetylation and deacetylation mechanism and for one - carbon metabolism [ 71, 72 ].	"Curcumin	0	8	Chemical/Drug"	"resveratrol	10	21	Chemical/Drug"	"polyphenols	23	34	Chemical/Drug"	"flavonoids	39	49	Chemical/Drug"	"phytoestrogen	51	64	Chemical/Drug"	"lycopene	70	78	Chemical/Drug"	"[{""token"": ""Curcumin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""resveratrol"", ""start_span"": 10, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""polyphenols"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""flavonoids"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""phytoestrogen"", ""start_span"": 51, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""lycopene"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Chemical/Drug""}]"
These genes are designated GmPT1 ( accession number HQ392508) and GmPT2 ( accession number HQ392509 ), respectively. GmPT1 is 1841 - bp long ( Figure 1A) and contains an open reading frame encoding a 536 amino acid polypeptide ( molecular mass 58730. 46 Da ). GmPT2 is 1802 bp long ( Figure 1A) and contains an open reading frame encoding a 536 amino acid polypeptide ( molecular mass 58627. 29 Da ).	"GmPT1	27	32	Gene/Protein"	"GmPT2	66	71	Gene/Protein"	"GmPT1	117	122	Gene/Protein"	"amino acid	204	214	Chemical/Drug"	"GmPT2	260	265	Gene/Protein"	"amino acid	345	355	Chemical/Drug"	"[{""token"": ""GmPT1"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""GmPT1"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""amino acid"", ""start_span"": 204, ""end_span"": 214, ""type"": ""Chemical/Drug""}, {""token"": ""GmPT2"", ""start_span"": 260, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""amino acid"", ""start_span"": 345, ""end_span"": 355, ""type"": ""Chemical/Drug""}]"
To verify the subcellular locations of GmPT1 and GmPT2, a green fluorescent protein ( GFP )- tagged gene was fused to the 3 ′ end of the open reading frame of the GmPT1 or GmPT2 genes.	"GmPT1	39	44	Gene/Protein"	"GmPT2	49	54	Gene/Protein"	"green fluorescent protein	58	83	Gene/Protein"	"GFP	86	89	Gene/Protein"	"GmPT1	163	168	Gene/Protein"	"GmPT2	172	177	Gene/Protein"	"[{""token"": ""GmPT1"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""green fluorescent protein"", ""start_span"": 58, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""GmPT1"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Gene/Protein""}]"
Our studies provide the first insights into the molecular nature of the proteins involved in phosphate transport in the soybean and reveal that soybean has phosphate transporters with sequence similarity to proton - coupled symporters from a large number of plants and fungi.	"soybean	120	127	Organism/Species"	"soybean	144	151	Organism/Species"	"phosphate transporters	156	178	Gene/Protein"	"proton - coupled symporters	207	234	Gene/Protein"	"plants	258	264	Organism/Species"	"fungi	269	274	Organism/Species"	"[{""token"": ""soybean"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""soybean"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""phosphate transporters"", ""start_span"": 156, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""proton - coupled symporters"", ""start_span"": 207, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 258, ""end_span"": 264, ""type"": ""Organism/Species""}, {""token"": ""fungi"", ""start_span"": 269, ""end_span"": 274, ""type"": ""Organism/Species""}]"
The subphylum vertebrata, which encompasses all of the large animal species, contains five main groups: fishes, amphibians, birds, reptiles and mammals.	"animal	61	67	Organism/Species"	"fishes	104	110	Organism/Species"	"amphibians	112	122	Organism/Species"	"birds	124	129	Organism/Species"	"reptiles	131	139	Organism/Species"	"mammals	144	151	Organism/Species"	"[{""token"": ""animal"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""fishes"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""amphibians"", ""start_span"": 112, ""end_span"": 122, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Organism/Species""}, {""token"": ""reptiles"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""mammals"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Organism/Species""}]"
Denervated paws did not respond to the hot stimuli on the lateral region until 45 dpi and at this time point group LM + MP. NGF / NT3 showed a shorter latency compared to control, FN and FN + MP. BDNF groups ( p < 0. 01; Figure 4D ), indicating that more sensory fibers arrived to the plantar skin of the paw.	"LM	115	117	Gene/Protein"	"NGF	124	127	Gene/Protein"	"NT3	130	133	Gene/Protein"	"FN	180	182	Gene/Protein"	"FN	187	189	Gene/Protein"	"BDNF	196	200	Gene/Protein"	"[{""token"": ""LM"", ""start_span"": 115, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 180, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 187, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Gene/Protein""}]"
It has been described that after injury integrin receptors α7β1 and α5β1 are upregulated in both motor and sensory neurons [ 14, 34 ], whereas high affinity TrkA and TrkC receptors are expressed in sensory neurons and TrKB is mainly expressed in motoneurons and in a low percentage of sensory neurons [ 35 ].	"injury	33	39	Disease/Disorder"	"integrin receptors α7β1	40	63	Gene/Protein"	"α5β1	68	72	Gene/Protein"	"TrkA	157	161	Gene/Protein"	"TrkC	166	170	Gene/Protein"	"TrKB	218	222	Gene/Protein"	"[{""token"": ""injury"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Disease/Disorder""}, {""token"": ""integrin receptors \u03b17\u03b21"", ""start_span"": 40, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""\u03b15\u03b21"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""TrkA"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""TrkC"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""TrKB"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Gene/Protein""}]"
NTF enriched substrates were prepared by adding BDNF at 50 ng / mL ( Peprotech, London, UK) or NGF and NT3 ( Peprotech) at 25 ng / mL each, and fibronectin ( BD Bioscences, Vienna, Austria) or laminin type I ( Sigma) to a 20% final volume.	"NTF	0	3	Gene/Protein"	"BDNF	48	52	Gene/Protein"	"NGF	95	98	Gene/Protein"	"NT3	103	106	Gene/Protein"	"fibronectin	144	155	Gene/Protein"	"laminin type I	193	207	Gene/Protein"	"[{""token"": ""NTF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""laminin type I"", ""start_span"": 193, ""end_span"": 207, ""type"": ""Gene/Protein""}]"
Each preparation of NTF was then added to ECM solutions prepared as for the cultures, i. e ., collagen at 3 mg / mL, collagen supplemented with laminin 20% ( v / v ), and collagen supplemented with fibronectin 20% ( v / v ).	"NTF	20	23	Gene/Protein"	"collagen	94	102	Gene/Protein"	"collagen	117	125	Gene/Protein"	"laminin	144	151	Gene/Protein"	"collagen	171	179	Gene/Protein"	"fibronectin	198	209	Gene/Protein"	"[{""token"": ""NTF"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""collagen"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""collagen"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""laminin"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""collagen"", ""start_span"": 171, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 198, ""end_span"": 209, ""type"": ""Gene/Protein""}]"
Metabolic strategies concerning the following have been investigated for α - KG production: regulation of key enzymes, including pyruvate dehydrogenase complex9, pyruvate carboxylase10, fumarase3, aconitase11, isocitrate lyase12, isocitrate dehydrogenase13 and components of the α - ketoglutarate dehydrogenase complex14; and co - factor engineering of acetyl - CoA biosynthesis and regeneration15.	"pyruvate dehydrogenase complex9	129	160	Gene/Protein"	"pyruvate carboxylase10	162	184	Gene/Protein"	"aconitase11	197	208	Gene/Protein"	"isocitrate lyase12	210	228	Gene/Protein"	"isocitrate dehydrogenase13	230	256	Gene/Protein"	"α - ketoglutarate dehydrogenase	279	310	Gene/Protein"	"[{""token"": ""pyruvate dehydrogenase complex9"", ""start_span"": 129, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""pyruvate carboxylase10"", ""start_span"": 162, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""aconitase11"", ""start_span"": 197, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""isocitrate lyase12"", ""start_span"": 210, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""isocitrate dehydrogenase13"", ""start_span"": 230, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""\u03b1 - ketoglutarate dehydrogenase"", ""start_span"": 279, ""end_span"": 310, ""type"": ""Gene/Protein""}]"
When intracellular α - KG levels increased, the expression of YALI0D20108g, YALI0C21406g, YALI0D24607g, and YALI0E32901g decreased by 3. 72 ± 0. 91 - fold, 3. 88 ± 0. 34 - fold, 2. 47 ± 0. 52 - fold, and 1. 60 ± 0. 18 - fold, respectively, whereas the expression of YALI0B19470g and YALI0C15488g increased by 9. 39 ± 0. 82 - fold and 4. 32 ± 0. 83 - fold, respectively.	"YALI0D20108g	62	74	Gene/Protein"	"YALI0C21406g	76	88	Gene/Protein"	"YALI0D24607g	90	102	Gene/Protein"	"YALI0E32901g	108	120	Gene/Protein"	"YALI0B19470g	266	278	Gene/Protein"	"YALI0C15488g	283	295	Gene/Protein"	"[{""token"": ""YALI0D20108g"", ""start_span"": 62, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C21406g"", ""start_span"": 76, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D24607g"", ""start_span"": 90, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""YALI0E32901g"", ""start_span"": 108, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""YALI0B19470g"", ""start_span"": 266, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C15488g"", ""start_span"": 283, ""end_span"": 295, ""type"": ""Gene/Protein""}]"
When incubated with PA, expression of YALI0D20108g, YALI0C21406g, YALI0D24607g, and YALI0E32901g decreased by 5. 83 ± 0. 81 - fold, 4. 04 ± 1. 04 - fold, 6. 44 ± 0. 98 - fold, and 15. 88 ± 1. 94 - fold, respectively, whereas expression of YALI0B19470g and YALI0C15488g increased by 2. 83 ± 0. 21 - fold and 9. 72 ± 0. 22 - fold, respectively ( Fig. 4B ).	"YALI0D20108g	38	50	Gene/Protein"	"YALI0C21406g	52	64	Gene/Protein"	"YALI0D24607g	66	78	Gene/Protein"	"YALI0E32901g	84	96	Gene/Protein"	"YALI0B19470g	239	251	Gene/Protein"	"YALI0C15488g	256	268	Gene/Protein"	"[{""token"": ""YALI0D20108g"", ""start_span"": 38, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C21406g"", ""start_span"": 52, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D24607g"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""YALI0E32901g"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""YALI0B19470g"", ""start_span"": 239, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C15488g"", ""start_span"": 256, ""end_span"": 268, ""type"": ""Gene/Protein""}]"
The hp4d promoter was used to increase the transcription of these genes, and YALI0B19470g, YALI0C15488g, YALI0C21406g, YALI0D24607g, YALI0D20108g and YALI0E32901g expression was improved by 23. 34 ± 2. 67 - fold, 8. 53 ± 0. 90 - fold, 9. 32 ± 0. 82 - fold, 11. 79 ± 1. 32 - fold, 3. 37 ± 0. 49 - fold and 10. 50 ± 0. 97 - fold, respectively ( Fig. 7 ).	"YALI0B19470g	77	89	Gene/Protein"	"YALI0C15488g	91	103	Gene/Protein"	"YALI0C21406g	105	117	Gene/Protein"	"YALI0D24607g	119	131	Gene/Protein"	"YALI0D20108g	133	145	Gene/Protein"	"YALI0E32901g	150	162	Gene/Protein"	"[{""token"": ""YALI0B19470g"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C15488g"", ""start_span"": 91, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C21406g"", ""start_span"": 105, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D24607g"", ""start_span"": 119, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D20108g"", ""start_span"": 133, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""YALI0E32901g"", ""start_span"": 150, ""end_span"": 162, ""type"": ""Gene/Protein""}]"
In Kluyveromyces lactis, the presence of two carboxylate transporters, Jen1p and Jen2p, guaranteed efficient uptake of lactic acid as a substrate from a lactic - acid - producing habitat30.	"Kluyveromyces lactis	3	23	Organism/Species"	"carboxylate transporters	45	69	Gene/Protein"	"Jen1p	71	76	Gene/Protein"	"Jen2p	81	86	Gene/Protein"	"lactic acid	119	130	Chemical/Drug"	"lactic - acid	153	166	Chemical/Drug"	"[{""token"": ""Kluyveromyces lactis"", ""start_span"": 3, ""end_span"": 23, ""type"": ""Organism/Species""}, {""token"": ""carboxylate transporters"", ""start_span"": 45, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Jen1p"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""Jen2p"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""lactic acid"", ""start_span"": 119, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""lactic - acid"", ""start_span"": 153, ""end_span"": 166, ""type"": ""Chemical/Drug""}]"
The loxP - URA3 - loxP and loxP - LEU2 - loxP modules were amplified from plasmids pUG72 and pUG73, respectively, with oligonucleotides JEN - MF / JEN - MR, ADY - MF / ADY - MR, respectively ( Table 5 ).	"URA3	11	15	Gene/Protein"	"LEU2	34	38	Gene/Protein"	"JEN	136	139	Gene/Protein"	"JEN	147	150	Gene/Protein"	"ADY	157	160	Gene/Protein"	"ADY	168	171	Gene/Protein"	"[{""token"": ""URA3"", ""start_span"": 11, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""LEU2"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""JEN"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""JEN"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""ADY"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""ADY"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Gene/Protein""}]"
Two fragments of ScJEN1 were amplified from S. cerevisiae genomic DNA and were subsequently flanked by the loxP - URA3 - loxP module to generate the JEN1 disruption cassette. ScADY2 fragments, PCR - amplified from S. cerevisiae genomic DNA, were flanked with the loxP - LEU2 - loxP module to generate the ADY2 disruption cassette.	"ScJEN1	17	23	Gene/Protein"	"URA3	114	118	Gene/Protein"	"JEN1	149	153	Gene/Protein"	"ScADY2	175	181	Gene/Protein"	"LEU2	270	274	Gene/Protein"	"ADY2	305	309	Gene/Protein"	"[{""token"": ""ScJEN1"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""URA3"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""JEN1"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""ScADY2"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""LEU2"", ""start_span"": 270, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""ADY2"", ""start_span"": 305, ""end_span"": 309, ""type"": ""Gene/Protein""}]"
The YALI0B19470g, YALI0C15488g, YALI0C21406g, YALI0D24607g, YALI0D20108g, and YALI0E32901g open reading frames were PCR - amplified from Y. lipolytica WSH - Z06 genomic DNA with the oligonucleotides listed in Table 7.	"YALI0B19470g	4	16	Gene/Protein"	"YALI0C15488g	18	30	Gene/Protein"	"YALI0C21406g	32	44	Gene/Protein"	"YALI0D24607g	46	58	Gene/Protein"	"YALI0D20108g	60	72	Gene/Protein"	"YALI0E32901g	78	90	Gene/Protein"	"[{""token"": ""YALI0B19470g"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C15488g"", ""start_span"": 18, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C21406g"", ""start_span"": 32, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D24607g"", ""start_span"": 46, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D20108g"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""YALI0E32901g"", ""start_span"": 78, ""end_span"": 90, ""type"": ""Gene/Protein""}]"
( A) YALI0B19470p, ( B) YALI0C15488p, ( C) YALI0C21406p, ( D) YALI0D24607p, ( E) YALI0D20108p, ( F) YALI0E32901p.	"YALI0B19470p	5	17	Gene/Protein"	"YALI0C15488p	24	36	Gene/Protein"	"YALI0C21406p	43	55	Gene/Protein"	"YALI0D24607p	62	74	Gene/Protein"	"YALI0D20108p	81	93	Gene/Protein"	"YALI0E32901p	100	112	Gene/Protein"	"[{""token"": ""YALI0B19470p"", ""start_span"": 5, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C15488p"", ""start_span"": 24, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C21406p"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D24607p"", ""start_span"": 62, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D20108p"", ""start_span"": 81, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""YALI0E32901p"", ""start_span"": 100, ""end_span"": 112, ""type"": ""Gene/Protein""}]"
WT: S. cerevisiae CEN. PK2 - 1D; W1: S. cerevisiae CEN. PK2 - 1D Δjen1; W2: S. cerevisiae CEN. PK2 - 1D Δjen1Δady2; W3: S. cerevisiae CEN. PK2 - 1D Δjen1Δady2 ( pY13 - TEF1 - 470 ); W4: S. cerevisiae CEN. PK2 - 1D Δjen1Δady2 ( pY13 - TEF1 - 488 ); W5: S. cerevisiae CEN. PK2 - 1D Δjen1Δady2 ( pY13 - TEF1 - 406 ); W6: S. cerevisiae CEN. PK2 - 1D Δjen1Δady2 ( pY13 - TEF1 - 607 ); W7: S. cerevisiae CEN. PK2 - 1D Δjen1Δady2 ( pY13 - TEF1 - 108 ); W8: S. cerevisiae CEN. PK2 - 1D Δjen1Δady2 ( pY13 - TEF1 - 901 ).	"TEF1	168	172	Gene/Protein"	"TEF1	234	238	Gene/Protein"	"TEF1	300	304	Gene/Protein"	"TEF1	366	370	Gene/Protein"	"TEF1	432	436	Gene/Protein"	"TEF1	498	502	Gene/Protein"	"[{""token"": ""TEF1"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 234, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 300, ""end_span"": 304, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 366, ""end_span"": 370, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 432, ""end_span"": 436, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 498, ""end_span"": 502, ""type"": ""Gene/Protein""}]"
Copy number of YALI0B19470g in T1, YALI0C15488g in T2, YALI0C21406g in T3, YALI0D24607g in T4, YALI0D20108g in T5 and YALI0E32901g in T6 were determined through qPCR analysis.	"YALI0B19470g	15	27	Gene/Protein"	"YALI0C15488g	35	47	Gene/Protein"	"YALI0C21406g	55	67	Gene/Protein"	"YALI0D24607g	75	87	Gene/Protein"	"YALI0D20108g	95	107	Gene/Protein"	"YALI0E32901g	118	130	Gene/Protein"	"[{""token"": ""YALI0B19470g"", ""start_span"": 15, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C15488g"", ""start_span"": 35, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C21406g"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D24607g"", ""start_span"": 75, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D20108g"", ""start_span"": 95, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""YALI0E32901g"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Gene/Protein""}]"
The strains T1 - T6 were mutant variants in which plasmid p0 ( hph )- 470, p0 ( hph )- 488, p0 ( hph )- 406 p0 ( hph )- 607, p0 ( hph )- 108 and p0 ( hph )- 901 were individually expressed in the wild - type strain.	"hph	63	66	Gene/Protein"	"hph	80	83	Gene/Protein"	"hph	97	100	Gene/Protein"	"hph	113	116	Gene/Protein"	"hph	130	133	Gene/Protein"	"hph	150	153	Gene/Protein"	"[{""token"": ""hph"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}]"
The transcription of YALI0B19470g, YALI0C15488g, YALI0C21406g, YALI0D24607g, YALI0D20108g, and YALI0E32901g increased by 23. 34 ± 2. 67 - fold, 8. 53 ± 0. 90 - fold, 9. 32 ± 0. 82 - fold, 11. 79 ± 1. 32 - fold, 3. 37 ± 0. 49 - fold and 10. 50 ± 0. 97 - fold, respectively.	"YALI0B19470g	21	33	Gene/Protein"	"YALI0C15488g	35	47	Gene/Protein"	"YALI0C21406g	49	61	Gene/Protein"	"YALI0D24607g	63	75	Gene/Protein"	"YALI0D20108g	77	89	Gene/Protein"	"YALI0E32901g	95	107	Gene/Protein"	"[{""token"": ""YALI0B19470g"", ""start_span"": 21, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C15488g"", ""start_span"": 35, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C21406g"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D24607g"", ""start_span"": 63, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D20108g"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""YALI0E32901g"", ""start_span"": 95, ""end_span"": 107, ""type"": ""Gene/Protein""}]"
The strains T1 – T6 were mutant variants in which plasmid p0 ( hph )- 470, p0 ( hph )- 488, p0 ( hph )- 406 p0 ( hph )- 607, p0 ( hph )- 108 and p0 ( hph )- 901 were individually expressed in the wild - type strain.	"hph	63	66	Gene/Protein"	"hph	80	83	Gene/Protein"	"hph	97	100	Gene/Protein"	"hph	113	116	Gene/Protein"	"hph	130	133	Gene/Protein"	"hph	150	153	Gene/Protein"	"[{""token"": ""hph"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}]"
MATα Δura3 - 52; Δtrp1 - 289; Δleu2 - 3, 112; Δhis3 - 1; MAL2 - 8C; SUC2; Δjen1 :: URA3; Δady2 :: LEU2 ( pY13 - TEF1 - 470)	"MATα	0	4	Gene/Protein"	"MAL2	57	61	Gene/Protein"	"SUC2	68	72	Gene/Protein"	"URA3	83	87	Gene/Protein"	"LEU2	98	102	Gene/Protein"	"TEF1	112	116	Gene/Protein"	"[{""token"": ""MAT\u03b1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""MAL2"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""SUC2"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""URA3"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""LEU2"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}]"
MATα Δura3 - 52; Δtrp1 - 289; Δleu2 - 3, 112; Δhis3 - 1; MAL2 - 8C; SUC2; Δjen1 :: URA3; Δady2 :: LEU2 ( pY13 - TEF1 - 488)	"MATα	0	4	Gene/Protein"	"MAL2	57	61	Gene/Protein"	"SUC2	68	72	Gene/Protein"	"URA3	83	87	Gene/Protein"	"LEU2	98	102	Gene/Protein"	"TEF1	112	116	Gene/Protein"	"[{""token"": ""MAT\u03b1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""MAL2"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""SUC2"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""URA3"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""LEU2"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}]"
MATα Δura3 - 52; Δtrp1 - 289; Δleu2 - 3, 112; Δhis3 - 1; MAL2 - 8C; SUC2; Δjen1 :: URA3; Δady2 :: LEU2 ( pY13 - TEF1 - 406)	"MATα	0	4	Gene/Protein"	"MAL2	57	61	Gene/Protein"	"SUC2	68	72	Gene/Protein"	"URA3	83	87	Gene/Protein"	"LEU2	98	102	Gene/Protein"	"TEF1	112	116	Gene/Protein"	"[{""token"": ""MAT\u03b1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""MAL2"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""SUC2"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""URA3"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""LEU2"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}]"
MATα Δura3 - 52; Δtrp1 - 289; Δleu2 - 3, 112; Δhis3 - 1; MAL2 - 8C; SUC2; Δjen1 :: URA3; Δady2 :: LEU2 ( pY13 - TEF1 - 607)	"MATα	0	4	Gene/Protein"	"MAL2	57	61	Gene/Protein"	"SUC2	68	72	Gene/Protein"	"URA3	83	87	Gene/Protein"	"LEU2	98	102	Gene/Protein"	"TEF1	112	116	Gene/Protein"	"[{""token"": ""MAT\u03b1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""MAL2"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""SUC2"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""URA3"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""LEU2"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}]"
MATα Δura3 - 52; Δtrp1 - 289; Δleu2 - 3, 112; Δhis3 - 1; MAL2 - 8C; SUC2; Δjen1 :: URA3; Δady2 :: LEU2 ( pY13 - TEF1 - 108)	"MATα	0	4	Gene/Protein"	"MAL2	57	61	Gene/Protein"	"SUC2	68	72	Gene/Protein"	"URA3	83	87	Gene/Protein"	"LEU2	98	102	Gene/Protein"	"TEF1	112	116	Gene/Protein"	"[{""token"": ""MAT\u03b1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""MAL2"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""SUC2"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""URA3"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""LEU2"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}]"
MATα Δura3 - 52; Δtrp1 - 289; Δleu2 - 3, 112; Δhis3 - 1; MAL2 - 8C; SUC2; Δjen1 :: URA3; Δady2 :: LEU2 ( pY13 - TEF1 - 901)	"MATα	0	4	Gene/Protein"	"MAL2	57	61	Gene/Protein"	"SUC2	68	72	Gene/Protein"	"URA3	83	87	Gene/Protein"	"LEU2	98	102	Gene/Protein"	"TEF1	112	116	Gene/Protein"	"[{""token"": ""MAT\u03b1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""MAL2"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""SUC2"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""URA3"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""LEU2"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}]"
High expression of CD29, CD73, CD90 and CD105 was observed, but CD34 and CD45 were down - regulated ( data not shown ).	"CD29	19	23	Gene/Protein"	"CD73	25	29	Gene/Protein"	"CD90	31	35	Gene/Protein"	"CD105	40	45	Gene/Protein"	"CD34	64	68	Gene/Protein"	"CD45	73	77	Gene/Protein"	"[{""token"": ""CD29"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""CD73"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""CD90"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""CD105"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""CD45"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}]"
MSC1 - based treatment of established tumors in an immune competent model attenuated tumor growth and metastasis in contrast to MSC - or MSC2 - treated animals in which tumor growth and spread was increased [ 23 ].	"MSC1	0	4	Gene/Protein"	"tumors	38	44	Disease/Disorder"	"tumor	85	90	Disease/Disorder"	"MSC2	137	141	Gene/Protein"	"animals	152	159	Organism/Species"	"tumor	169	174	Disease/Disorder"	"[{""token"": ""MSC1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Disease/Disorder""}, {""token"": ""MSC2"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""animals"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Organism/Species""}, {""token"": ""tumor"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Disease/Disorder""}]"
Mice were divided into three groups ( n = 6 per group ): the MSCs group, in which mice received co - injection of 1 × 106 MSCs and tumor cells in PBS; the cMSCs group, in which mice received the same amount of M1 medium - treated MSCs and cancer cells; and the control ( PBS) group received only PBS and cancer cells.	"Mice	0	4	Organism/Species"	"mice	82	86	Organism/Species"	"tumor	131	136	Disease/Disorder"	"mice	177	181	Organism/Species"	"cancer	239	245	Disease/Disorder"	"cancer	304	310	Disease/Disorder"	"[{""token"": ""Mice"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Organism/Species""}, {""token"": ""tumor"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Organism/Species""}, {""token"": ""cancer"", ""start_span"": 239, ""end_span"": 245, ""type"": ""Disease/Disorder""}, {""token"": ""cancer"", ""start_span"": 304, ""end_span"": 310, ""type"": ""Disease/Disorder""}]"
To quantify tumor - associated bone marrow cell recruitment, the tumor sections were stained with rat anti - mouse CD45 ( BD Biosciences Pharmingen, San Diego, CA ), and the percentage of CD45 - positive cells was determined by counting the number of cells in six random fields ( 400 × magnification) from three histology sections.	"tumor	12	17	Disease/Disorder"	"tumor	65	70	Disease/Disorder"	"rat	98	101	Organism/Species"	"mouse	109	114	Organism/Species"	"CD45	115	119	Gene/Protein"	"CD45	188	192	Gene/Protein"	"[{""token"": ""tumor"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Disease/Disorder""}, {""token"": ""rat"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Organism/Species""}, {""token"": ""CD45"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""CD45"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Gene/Protein""}]"
To measure macrophage infiltration in the tumor sites and blood, the tumor cells and peripheral cells were stained with Alexa Fluor ® 594 - conjugated rabbit anti - mouse CD206 ( Abcam, Cambridge, MA) and FITC - labeled anti - mouse F4 / 80 ( Abcam, Cambridge, MA ).	"tumor	42	47	Disease/Disorder"	"tumor	69	74	Disease/Disorder"	"rabbit	151	157	Organism/Species"	"mouse	165	170	Organism/Species"	"CD206	171	176	Gene/Protein"	"mouse	227	232	Organism/Species"	"[{""token"": ""tumor"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Disease/Disorder""}, {""token"": ""rabbit"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Organism/Species""}, {""token"": ""CD206"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 227, ""end_span"": 232, ""type"": ""Organism/Species""}]"
The identification of mutations in TSC1 and TSC2 and the existence of a licensed drug targeting the mTOR pathway, lead to rapid translation of mTOR inhibitors to patients with TSC and LAM.	"TSC1	35	39	Gene/Protein"	"TSC2	44	48	Gene/Protein"	"mTOR	100	104	Gene/Protein"	"mTOR	143	147	Gene/Protein"	"TSC	176	179	Disease/Disorder"	"LAM	184	187	Disease/Disorder"	"[{""token"": ""TSC1"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""TSC2"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""mTOR"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""mTOR"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""TSC"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Disease/Disorder""}, {""token"": ""LAM"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Disease/Disorder""}]"
a Abbreviations: BMI: body mass index; BP: blood pressure; CHD: coronary heart disease; CV: cardiovascular; CVD: cardiovascular disease; CVRM: cardiovascular risk management; DM: diabetes mellitus; GP: general practitioner.	"CHD	59	62	Disease/Disorder"	"coronary heart disease	64	86	Disease/Disorder"	"CVD	108	111	Disease/Disorder"	"cardiovascular disease	113	135	Disease/Disorder"	"DM	175	177	Disease/Disorder"	"diabetes mellitus	179	196	Disease/Disorder"	"[{""token"": ""CHD"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Disease/Disorder""}, {""token"": ""coronary heart disease"", ""start_span"": 64, ""end_span"": 86, ""type"": ""Disease/Disorder""}, {""token"": ""CVD"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Disease/Disorder""}, {""token"": ""cardiovascular disease"", ""start_span"": 113, ""end_span"": 135, ""type"": ""Disease/Disorder""}, {""token"": ""DM"", ""start_span"": 175, ""end_span"": 177, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes mellitus"", ""start_span"": 179, ""end_span"": 196, ""type"": ""Disease/Disorder""}]"
